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SHROOM2 REGULATES ENDOTHELIAL MORPHOGENESIS AND 
CENTROSOME DUPLICATION THROUGH THE SPECIFIC SUB-CELLULAR 
RECRUITMENT OF RHO-KINASE.  
 
Matthew J. Farber, Ph.D. 
University of Pittsburgh, 2011
 
The ability of epithelial cells to change shape is essential to the patterning of tissues and organs 
during development of the vertebrate embryo.  Epithelial morphogenesis is mediated by the 
molecular regulation of cytoskeletal dynamics which underlies cellular adhesion, motility, 
polarity, and proliferation.  The Shroom family of proteins regulates epithelial morphogenesis by 
promoting MyosinII-dependent changes in epithelial morphology through the ability to bind both 
F-actin and Rho kinase (Rock). Shroom3 is necessary to induce apical constriction of the neural 
epithelium and is required for proper neural tube closure during development.  However, the 
roles of other family members are unknown.  This work seeks to determine the role and 
mechanism of action for Shroom2 in epithelial cell biology. 
Through RNAi, the loss of Shroom2 reduces contractility of endothelial cells.  Shroom2 
physically interacts with Rock and is necessary for its cortical localization.  By impeding Rock 
localization and reducing contractility, Shroom2 knockdown alters cytoskeletal organization, 
adhesion, and motility which ultimately affects in vitro angiogenesis.  During these studies, it 
also became clear that Shroom2 localizes to the centrosome where it is required to maintain 
efficient centrosome duplication in a Rock-dependent manner.  The results described here 
expand a role for the Shroom proteins in the sub-cellular localization of Rock which mediates a 
subset of Rock functions within epithelial cells. 
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1.0  INTRODUCTION 
Epithelial morphogenesis is the process in which cells change shape in order to pattern diverse 
organ shape and function.  Cellular functions such as motility, polarity, adhesion, and 
cytoskeletal dynamics are essential in specifying cell shape changes.  Understanding the various 
mechanisms behind epithelial morphogenesis provides insight into animal development, 
congenital diseases, regeneration, and tissue engineering.   
An epithelium is typically a polarized monolayer of cells where cell adhesion is essential 
for the formation of coherent sheets [1].  Subsequent changes in cell shape, intercalation, 
migration, proliferation, and apoptosis pattern more complex structures and forms the variety of 
tissues and organs of the body.  A variety of mechanistic processes facilitate such shape changes.  
First, extracellular cues such as morphogens, the extracellular matrix, and physical forces initiate 
signal transduction to cells.  Second, cells must possess the ability to transduce such signals 
through integrins and cellular adhesion structures.  Third, as an outcome of signal transduction, 
cells must physically change their shape by altering the cytoskeleton and adhesive properties.  
And finally, cell morphogenesis can be specified by specific transcription factor profiles [2].  By 
varying the expression of signal transduction pathway components, the cell’s ability to sense 
cues and execute morphogenesis can change.  While this dissertation will discuss many of these 
processes, the focus will be on understanding cytoskeletal dynamics which influence epithelial 
morphogenesis through adhesion, migration, and contractility. 
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1.1 ACTIN DYNAMICS 
The most basic element of cell shape change is the cytoskeleton.  Just as a building cannot stand 
without a wooden, steel, or concrete infrastructure, a cell cannot take form without the 
cytoskeleton.  The complex networks of actin filaments, microtubules (MT), and intermediate 
filaments (IF) make up the structural integrity of the cell and are responsible for a variety of 
cellular functions such as mitosis, migration, adhesion, and intracellular transportation.  
Microtubules are long, hollow cylinders with subunits of  and  tubulin heterodimers and are 
best known for their role in bi-polar spindle formation and chromosome segregation during 
mitosis [3].  They also play a structural role and provide intracellular networks on which to 
transport cargo.  IFs consist of coiled-coil dimers which closely interact to form a rope-like 
filament [4].  IFs are best known for formation of a meshwork lining within the nuclear 
membrane.  Within the cytoplasm, it is believed that IF networks impart physical strength to the 
cell.  Actin is composed of a single monomer of globular (G) actin which polymerizes into two-
stranded helices termed filamentous (F) actin [5].  Actin is closely associated with the plasma 
membrane, and as such, remodeling of the actin cytoskeleton greatly influences cell morphology.  
Changes in actin architecture underlie changes in cell migration, adhesion, and contractility.  The 
molecular mechanisms of these processes are described in subsequent sections. 
1.1.1 Actin binding proteins 
Based upon the head-to-tail alignment of actin monomers within a filament, F-actin contains 
inherent polarity with a “pointed” and “barbed” end [6].  F-actin elongates when ATP-bound 
monomers are added to the barbed end.  As the actin filament matures, ATP is hydrolysed and 
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the resulting ADP-actin monomers are released resulting in net depolymerization at the pointed 
end [7].  While actin can self polymerize, a variety of actin binding proteins are involved to 
expedite and control actin networks through regulation of the nucleation of new branches, the 
assembly and disassembly of existing fibers, and the organization of filaments into higher-order 
structures. 
Two primary types of actin networks are prevalent throughout the cell: long cables and 
short, branched networks.  The type of actin network depends upon the activity of nucleation 
promoting factors. For example, branched actin networks occur through the protein Arp2/3 
which nucleates filaments from the side of existing fibers [8].  This activity is enhanced by 
interactions with members of the Wiskott-Aldrich syndrome protein family (ex: WASP, WAVE, 
and WASH) which are thought to provide actin monomers to new branches [9].  In addition, 
cortactin binds to cortical F-actin and recruits and stabilizes Arp2/3.  Actin capping proteins such 
as gelsolin and capping protein, bind to the barbed end of F-actin and prevent the addition of new 
monomers [10].  By limiting the polymerization of exisiting filaments, capping protein also 
promotes Arp2/3 dependent branched network assembly [11].  Anti-capping proteins, such as the 
Ena/VASP family, can counter capping proteins by preferentially binding to the barbed end of F-
actin while simultaneously binding to G-actin, promoting long, unbranched filament assembly 
[12].  The formin family of proteins also binds to the barbed end and enhances polymerization of 
long filaments [13]. 
Several actin binding proteins have been identified which either promote strand stability 
or depolymerization.  The ADF/cofilin proteins remove ADP-actin from the pointed end thus 
promoting depolymerization [14].  In addition to capping function, gelsolin can act as a severing 
protein [15].  On the other hand, tropomyosin proteins bind along the filament length and 
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stabilize the filament from depolymerization [16].  While these proteins all interact with F-actin, 
certain proteins can interact with actin monomers.  With an affinity for G-actin, profilin 
sequesters the available pool of monomers and can prevent spontaneous actin assembly [17].  
Additionally, profilin promotes nucleotide exchange, converting less stable ADP-actin into 
filament friendly ATP-actin [18].  The addition of G-actin to the barbed end by Ena/VASP 
proteins is further enhanced by its ability to interact with profilin [19].  The molecular regulation 
of actin binding proteins and their roles in cell biology will be discussed in later sections. 
Just as more force is required to tear a stack of papers than a single sheet, bundles of actin 
can withstand greater stress than single fibers.  Some actin binding proteins organize F-actin into 
higher order networks by bundling or crosslinking actin fibers.  Parallel actin bundles can be 
formed in one of two ways.  First, certain actin binding proteins like -actinin are homodimers 
with a single actin binding domain [20].  As they dimerize, they can bind to two separate F-actin 
fibers leaving about 30nm of space between the fibers [21].  Other proteins like fimbrin and 
villin are small in size and possess two actin binding motifs [22, 23]. Therefore they bundle F-
actin into a tighter network (Figure 1).  
While -actinin and fimbrin form parallel actin networks, other proteins can form an 
actin web or gel.  Spectrin is a long, flexible tetramer with two actin binding domains 200nm 
apart [24].  As spectrin can bind to peripheral membrane proteins, spectrin forms a gel-like 
network of actin fibers at the cell cortex.  Filamin dimers position two actin binding domains at 
right angles and thus create a mesh-like network which is important for the formation of thin, flat 
lamellipodia during migration [25].  Depending on the organization of the actin network, 
different proteins gain access.  For example, non-muscle Myosin II cannot fit between the small 
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spaces of fimbrin packed actin fibers but fits well in the space created by -actinin.  The 
relationship between actin and myosin will be discussed in the next section. 
 
 
Figure 1: Actin binding proteins shape actin networks. 
(A) Fimbrin is a small protein with two actin binding domains which forms tightly packed parallel actin 
fibers.  (B) -actinin has one actin binding domain but dimerizes, thus forming more loosely packed 
parallel actin fibers.  (C) Spectrin is a long heterodimer with actin binding properties at either end.  (D)  
Spectrin forms a mesh like network with actin at the cortex of red blood cells.  (E)  Filamin has one actin 
binding domain but dimerizes to bind two actin fibers at right angles.  Figure adapted from [26]. 
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1.1.2 Non-muscle Myosin II 
Myosins contain a large family of motor proteins which are vital to cellular processes such as 
cytokinesis, intracellular transport, motility, and morphogenesis.  Through ATPase and actin 
binding activity, myosin transfers energy into protein conformational change allowing the 
molecules to exert force upon F-actin, be it by walking along filaments or exerting tension 
between them [27].  Non-muscle myosin II (MyosinII) is the largest class of myosin and is 
responsible for most myosin-dependent processes in non-muscle cells.  MyosinII contains three 
pairs of peptides: two myosin heavy chains (MHC), two myosin regulatory light chains (MRLC), 
and two myosin essential light chains (MELC).  The MHCs constitute the bulk of MyosinII and 
contain two globular heads, a neck region, and a long coiled-coil; the two heads contain the 
ATPase and the actin binding domain.  MRLC and MELC bind within the neck region, and the 
coiled-coil is responsible for dimerization and filament assembly [28].  While the globular head 
domain can bind to actin and exert force by itself, both ATPase activity and force exertion are 
greatly enhanced by phosphorylation of Ser19 in the MRLC [29].  In addition, it is thought that 
the MRLC is responsible for regulating actomyosin filament assembly.  In vitro, 
unphosphorylated MyosinII folds into a looped conformation through an interaction between the 
head and tail; globular heads are inaccessible to actin and the coiled-coil is unable to form 
filaments [30].  Phosphorylation of MRLC may disrupt the head to tail interaction, inducing 
polarized filament assembly as demonstrated in vitro through smooth muscle myosin [31].  
When MyosinII filaments bind to anti-parallel F-actin fibers, ATP hydrolysis induces a 
conformational change in the globular head which causes the F-actin fibers to contract.  
Contraction of actomyosin networks and their regulation are the fundamental basis of 
morphogenesis. 
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Many kinases have been linked to the phosphorylation of MRLC and activation of 
MyosinII such as Rho-kinase (Rock), Myosin light chain kinase (MLCK), citron kinase, Zipper 
interacting protein kinase (ZIPK), and myotonic dystrophy kinase-related CDC42-binding kinase 
(MRCK) [32-34].  These kinases target Ser19, Thr18, or both to relieve the inhibition described 
above, but the activation of each kinase differs.  For example, MLCK is activated by Ca2+ 
calmodulin signaling, whereas Rock and citron kinase are activated by RhoA.  As another 
difference, MLCK only phosphorylates MLC, whereas Rock targets additional effectors which 
are described in section 1.1.4.3 [35].  Protein kinase C (PKC) phosphorylates MLC on Ser1, 
Ser2, and Thr9, which hinders the interaction between MLC and MLCK, thus decreasing 
MyosinII activity [36]. 
  There are three different MHC genes in vertebrates which determine one of three 
MyosinII isoforms, A-C [37]. At least in vitro, it is apparent that the three differ in their kinetic 
properties.  MyosinIIA has the highest rate of ATP hydrolysis and contracts filaments more 
quickly than the other two [38].  MyosinIIB remains bound to F-actin in a force generating state 
longer than MyosinIIA [39].  And MyosinIIB possesses a higher affinity for ADP, the release of 
which is slowed by backward strains exerted by actin filaments [40].  Thus MyosinIIA may 
function in more rapid, dynamic contraction events, while MyosinIIB is engaged with actin 
filaments for a longer period of time to maintain tension.  Differential roles for MyosinII 
isoforms in cell function will be discussed below. 
1.1.3 Rho Family of p21 Small GTPases 
In order to elicit morphogenesis, the variety of actin networks within the cell must undergo 
remodeling through the molecular regulation of actin binding proteins and nucleation promoting 
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factors.  The Rho-family of p21 small GTPases regulate a variety of cellular proteins, including 
actin binding proteins, to influence cell functions such as motility, adhesion, and proliferation.  
Rho family GTPases are known as molecular switches, interacting with downstream effectors to 
continue signal transduction pathways [41].  GTPases are in the “on” state when bound to GTP 
and in the “off” state following intrinsic phosphatase activity which dephosphorylates GTP into 
GDP.  Hydrolysis of GTP by GTPases can be accelerated through interactions with GTPase 
activating proteins (GAPs), whereas the exchange of GDP for GTP is mediated by guanine-
nucleotide exchange factors (GEFs) [42, 43].  The relative affinity of a GTPase for its effector in 
GTP versus GDP bound states can be as high as 100-fold, leading to very specific effector 
interactions in the “on” state only [44].  An additional means of GTPase regulation comes by 
way of guanine-nucleotide dissociation inhibitors (GDIs).  By binding to GDP-bound GTPases, 
GDIs prevent nucleotide exchange and thus block activation of effectors [45]. 
The Rho family GTPases, RhoA, Rac1, and Cdc42, have been traditionally thought of as 
cytoskeletal regulators based on seminal work showing the effects of over expression in 
Swiss3T3 fibroblasts.  RhoA increased stress fiber and adhesion formation, Rac1 caused flat 
lamellipodial extensions, and Cdc42 induced filopodial extensions [46-48].  In the years since, it 
has become apparent that these changes in actin structures are due to the regulation of actin 
binding proteins.  For example, the mammalian formin Diaphanous (mDia) is an effector of Rho, 
and activation of mDia is sufficient to induce stress fibers [49].  As another example, Rac1 can 
activate WAVE proteins, a member of the WASP family [50].  WASP proteins contain an auto-
inhibitory region which is repressed upon binding to Rac1.  Following activation, WASP 
proteins can bind to Arp2/3 and induce branched actin networks as found in lamellipodia [51, 
52].   
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 Figure 2: Overview of Rho GTPase signaling 
Rho GTPases are molecular switches which contribute to signal transduction to influence cell functions.  GEFs and 
GAPs can influence the activity of GTPases by promoting the exchange of GDP for GTP (GEFs) or accelerating the 
hydrolysis of GTP (GAPs).  Additionally, GTPase activity can be sequestered through GDIs which bind GDP 
GTPases and prevent exchange of GTP.  Rho GTPases target a variety of proteins including actin nucleation 
proteins which influence actin dynamics, kinases which induce actomyosin contractility, and polarity proteins such 
as PAR3 which mediate cell polarity. 
1.1.4 Rho Kinase 
Rho kinase (Rock) is a Rho effector involved in cytoskeletal dynamics [53].  Functioning as a 
serine/threonine kinase, Rock is composed of an N-terminal catalytic domain, a central coiled-
coil domain, and a C-terminal Plekstrin homology (PH) domain.  In crystallographic studies, the 
N- and C-terminal extensions around the catalytic domain facilitate formation of a head-to-head 
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homodimer [54].  Because Rock forms multimeric complexes and does not elute as a monomer, 
it is likely that Rock dimerizes in a parallel orientation [55]. 
1.1.4.1 Rock1 and Rock2 
Two Rock isoforms exist in vertebrates, Rho-kinase  / p160ROCK / Rock1 and Rho-
kinase  / Rock2, both sharing 65% identity between amino acids overall and 83% identity 
within the kinase domain.  Rock1 and Rock2 are ubiquitously expressed in mouse tissues; 
however, Rock2 transcripts are more abundant in muscle and neural tissue, while higher levels of 
Rock1 are found in tissues such as the lung, liver, and testis [56].  There is also some evidence 
for differential regulation of Rock isoforms during apoptosis as Rock1 is cleaved by caspase-3, 
whereas Rock2 is cleaved by granzyme B [57, 58].  It has been speculated that Rock isoforms 
play different developmental roles, because mutant mice display different phenotypes.  Rock1-/- 
mice display eyelid and ventral closure defects, while Rock2-/- mice display placental 
dysfunction [59, 60].  However, it was subsequently shown that altering the genetic background 
of Rock2-/- mice also resulted in eyelid closure defects and umbilical herniation.  In support of 
functional redundancy between Rock1 and Rock2, heterozygosity for either Rock1 or Rock2 
yields no phenotype, whereas Rock1 +/- Rock2 +/- compound heterzygotes lead to eyelid close 
defects [61].  Additionally, Rock1 -/- Rock2 -/- embryos die between embryonic day (e) 3.5 and 
e9.5, but Rock1 -/- Rock2 +/- or Rock1 +/- Rock2 -/- embryos show defects in the yolk sac 
vasculature [62].  Based on these results and the lack of evidence for unique substrates for either 
isoform, it is likely that Rock1 and Rock2 function redundantly and from henceforth will simply 
be referred to as Rock. 
 10 
1.1.4.2 Activation of Rock 
Interaction with Rho at the C-terminus of the coiled-coil domain moderately activates 
Rock activity [63].  Rock is subject to intramolecular inhibition by the C-terminal half of the 
protein, and Rho is thought to relieve this inhibition.  Several lines of evidence support this 
hypothesis.  First, deletion or proteolytic cleavage of the C-terminus leads to constitutive 
activation of Rock [53, 57, 58].  Second, expression of the C-terminal region is sufficient to 
inhibit the constitutive active form of Rock [64].  And finally, an antibody against the Rho 
binding region of Rock induces Rock activity [55].  While most Rock-dependent activities 
require Rho, some lipids, especially arachidonic acid, can activate Rock independent of Rho 
[65].  In addition, it has been shown that interaction of DynaminI with the PH domain of Rock is 
sufficient to induce catalytic activity [66].  If the alleviation of intramolecular inhibition within 
Rock is a key event to its activation, then it is highly likely that other protein interactions within 
the PH domain or coiled-coil region are also sufficient to induce Rock activity. 
However, not all proteins that bind Rock activate its catalytic function.  Gem and Rad, 
members of a small GTP binding family of proteins within the Ras family, bind near the Rho-
binding motif but exert an inhibitory function.  While Gem and Rad do not directly affect Rock 
catalytic activity, it is likely that they block accessibility of other interactions [67].  Another 
Rock inhibitor, RhoE, is a member of the Rnd subfamily of GTP binding proteins.  RhoE binds 
near the kinase domain and interacts with Rock when it is activated by RhoA or cleaved by 
caspase.  Because RhoE binds near the catalytic domain, it is likely that interaction with RhoE 
blocks the interaction with yet-to-be-determined Rock effectors [68]. 
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1.1.4.3 Rock effectors and functions 
One of the key molecular regulatory mechanisms responsible for induction of contractile 
actomyosin is the balance between kinases that phosphorylate MRLC and the activity of Myosin 
light chain phosphatase.  Myosin phosphatase contains a catalytic subunit and two regulatory 
subunits, myosin phosphatase targeting subunit 1 (MYPT) and M20 [69]. As previously stated, 
phosphorylation of MRLC at Ser19 induces MyosinII contractility, whereas Myosin phosphatase 
acts to remove this phosphate and abrogate MyosinII activation.  Rock is at the crux of this 
balance, as it directly phosphorylates MRLC to increase ATPase activity [70] and also 
phosphorylates and inactivates MYPT [71].  Rock can also phosphorylate and activate ZIPK 
[72].  Similar to Rock, ZIPK also phosphorylates MYPT and MRLC, however the net 
contribution of ZIPK to Rock-induced contractility is unknown [34]. 
LIM kinases (LIMK) are serine/threonine kinases which influence actin dynamics.  Rock 
has been shown to phosphorylate both LIMK1 and LIMK2, which enhances LIMK activity and 
leads to phosphorylation of ADF/cofilin [73].  Phosphorylation of cofilin at this site inactivates 
the ability of cofilin to depolymerize actin [74].  Thus, Rock phosphorylation of LIMK 
inactivates cofilin and stabilizes F-actin.  However, Cdc42 and Rac can also promote LIMK 
phosphorylation [75].  Given that only CA-Rock and not full-length Rock activates LIMK [76], 
it is likely that the other Rho GTPases are the predominant cofilin mediators. 
Finally, Rock is important in the regulation of several proteins which link the actin 
cytoskeleton to the plasma membrane.  Adducin is a filamentous protein which binds to F-actin, 
attenuates polymerization, and recruits spectrin.  Phosphorylation of -adducin by Rock 
enhances actin binding [77].  The ERM (Ezrin-Radixin-Moesin) proteins also act to crosslink 
actin and transmembrane proteins.  Unphosphorylated ERM proteins retain a head to tail 
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conformation which masks actin and protein interaction domains.  Phosphorylation of ERM 
proteins by Rock disrupts the head to tail conformation and permits protein interactions [78].  
The molecular regulation of actomyosin contractility through Rho GTPases, Rock, and actin 
binding proteins is essential to drive morphogenesis of cells and tissues during development and 
will be discussed in more detail in subsequent sections. 
1.2 EPITHELIAL ADHESION 
Polarized epithelial cells are characterized by an apical surface which faces a lumen and a 
basolateral surface that contains adhesive structures which connect the lateral side with 
neighboring cells and the basal side with the underlying extracellular matrix (ECM) (Figure 3).  
Cellular adhesion is important for both transducing extracellular signals into morphogenetic 
responses and integrating cytoskeletal dynamics across a tissue.  Such interactions must be 
dynamic and strong in order to resist and respond to stress. Especially during development, as 
cells and tissues undergo dramatic changes in morphology, cellular adhesion must persist to 
maintain the integrity of the tissue.  Circumscribed along the apical-lateral region of epithelia are 
two distinct intercellular junctions, together referred to as the apical junctional complex (AJC).  
The AJC consists of lateral adherens junctions (AJ) which mediate cell-cell adhesion and apical 
tight junctions (TJ) which regulate the movement of molecules and cells through the epithelial 
monolayer.  Basal adhesion is mediated by focal adhesions (FA) which connect the cell to the 
ECM. 
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 Figure 3: Basic Epithelial Organization 
(A-B) Lungs from e11.5 mice were dissected and processed for SEM as described in section 5.17.  The 
region of magnification in A is marked with a box and presented in B.  The ECM can be seen as a 
meshwork of fibers which underlie the pulmonary epithelia. 
1.2.1 Tight Junctions 
The apical most adhesion structures within epithelia are TJs which are composed of the 
transmembrane proteins occludin [79], claudin [80], and junctional adhesion molecule (JAM) 
[81].  Tight junctions also contain many PSD/SAP90, Discs large, ZO-1 (PDZ) domain proteins 
which connect transmembrane proteins and the actin cytoskeleton.  PDZ domains are 
characteristic of scaffolding proteins and facilitate protein-protein interactions [82].  Though this 
100 amino acid domain occurs 785 times in 436 human proteins and shares structural similarity, 
PDZ domains greatly differ in their binding partners [83, 84]. 
Several PDZ-containing complexes are required for TJ assembly and apical-basal 
polarity.  For example, apical localization of the PAR-3/aPKC/PAR-6 complex is mediated by 
interaction of PAR-3 and JAM-1 [85, 86] and is required for later stages of TJ assembly [87].  
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Another polarity complex, Crumbs/PALS1/PATJ localizes to TJs through an interaction between 
PALS and PAR-6 [88].  Localization of this complex to the TJ is further enhanced by an 
interaction between PATJ and claudin-1 [89].  Expression of a dominant negative (D/N) PATJ 
disrupts apical localization of the PAR-3/aPKC/PAR-6 and the Crumbs/PALS1/PATJ complexes 
implicating it in maintaining polarity and TJs [88]. 
Additional PDZ proteins important for TJ structure are ZO-1, ZO-2, and ZO-3 [90-92].  
The ZO proteins are cytoplasmic proteins which can directly interact with each other, claudin, 
and occludin [93-95].  Because ZO proteins also interact with actin related proteins such as -
catenin, AF-6/afadin, and vinculin, it is thought that ZO proteins form scaffolding complexes 
which maintain connections between TJs and the actin cytoskeleton [95-97].  Additionally, the 
ZO proteins are essential for TJ formation as depletion of ZO-1 and ZO-2 in a model epithelial 
cell line completely abolishes TJ assembly [98].  However, disruption of ZO-1 or ZO-2 in mice 
leads to embryonic lethality due to failure in yolk sac angiogenesis or gastrulation, respectively 
[99, 100] suggesting these proteins may not function redundantly in every tissue.  ZO-3 mutants 
have no discernable phenotype [99]. 
In addition to proteins which serve as links between integral TJ proteins and the actin 
cytoskeleton, a variety of non-PDZ, cytosolic, and nuclear proteins have been identified as TJ 
associated proteins which coordinate diverse functions such as paracellular permeability, 
proliferation, and tumor suppression (reviewed in [101]).  
1.2.2 Adherens Junctions 
AJs were first identified through electron microscopy as plasma membrane “organelles” found at 
cell-cell contacts [102].  The primary adhesion molecule found in AJs are the classical cadherins, 
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such as E-cadherin, which are transmembrane proteins that engage in homophilic interactions 
[103].  Classic cadherins contain a highly conserved cytoplasmic tail which interacts with 
p120catenin and -catenin.  -catenin binds to -catenin, an F-actin binding protein, thus 
connecting the cadherin-catenin complex to the actin cytoskeleton. Although -catenin can 
directly bind to F-actin, it is also known to interact with several other actin binding proteins such 
as vinculin, formin, and ZO-1 [104, 105].  In Drosophila p120catenin and -catenin may serve 
little regulatory function at AJs and only act to connect cadherin to -catenin, because a 
cadherin--catenin fusion protein fully compensates for the loss of DE-cadherin or the -catenin 
homologue, Armadillo [106].  However, in mammalian cells, -catenin and p120catenin may 
regulate AJ stability, as loss of either protein increases cadherin turnover and endocytosis [107-
109].  Additionally p120 catenin and -catenin interact with kinesin and dynein respectively and 
may link cadherins to microtubules, facilitating the directed transport of AJ proteins [110, 111]. 
A second class of transmembrane proteins, nectins, also exists within AJs.  Nectins bind to 
AF6/afadin which interacts with F-actin.  Because afadin and -catenin can physically interact, it 
is thought that cadherins and nectins perform similar function at AJs [112, 113].  
Maintaining a connection between AJs and the actin cytoskeleton is critical to tissue 
morphogenesis.  During Drosophila gastrulation, the ventral epithelium apically constricts to 
promote invagination in a process dependent upon apical actomyosin.  Deletion of canoe, the 
Afadin homologue, leads to morphogenesis failure due to a disconnection of the cytoskeleton 
and AJs.  canoe mutants show a striking accumulation of actin and MyosinII in the center of the 
cell as the contractile arrays separate from the plasma membrane and accumulate in the middle 
[114].  This study highlights the necessity of AJs during epithelial morphogenesis. 
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1.2.3 Focal Adhesions 
FAs are vital protein complexes which link the cell to the extracellular matrix [115].  Integrins 
are the primary adhesive protein of FAs and consist of non-covalent heterodimers of  and  
subunits.  As transmembrane proteins, integrins have a large extracellular domain and a short 
cytoplasmic tail.  As the extracellular domain binds to specific ECM proteins, the tail changes 
conformation and facilitates the accumulation of a large protein complex with estimates of as 
many as 156 proteins with 690 interactions [116].  Similar to AJs, a network of actin binding 
proteins connects integrins to the cytoskeleton.  The best characterized are talin which initially 
binds and activates the cytoplasmic tail of integrins and vinculin which recruits another actin 
binding protein, -actinin [117, 118].  FAs also contain many scaffolding proteins such as 
paxillin and signaling proteins such as focal adhesion kinase (FAK) [119, 120].  Effectors of 
FAK include GEFs and GAPs which control activation of Rho-family GTPases and subsequently 
regulate contractility and F-actin organization.  An overview model of epithelial adhesion 
structures is presented in Figure 4. 
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 Figure 4: Model of Epithelial Adhesion Structures 
The tight junction (TJ) is the apical-most junction in an epithelial cell whose position is defined by the polarity 
complexes PAT-J/Crumbs/PALS1 and PAR-3/aPKC/PAR-6.  Through interactions with the transmembrane proteins 
occludin, claudin, and JAM, ZO proteins recruit the actin binding proteins catenin and vinculin to maintain a 
connection with the cytoskeleton.  Adherens junctions (AJs) along the lateral side involve cadherins which interact 
with p120 and -catenin.  -catenin can recruit a number of actin binding proteins to connect AJs with the actin 
cytoskeleton.  In addition, AJs serve as points of connection for MTs, since p120 and  -catenin can also interact 
with MT binding proteins.  Along the basal surface, focal adhesions (FAs) connect the epithelial cell to the 
underlying ECM.  Again through the recruitment of actin binding proteins, integrins maintain a connection with the 
cytoskeleton.  Additionally, FAs recuit signaling molecules like FAK to induce further changes in the cytoskeleton. 
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1.3 CONTRACTILE ACTOMYOSIN AND MORPHOGENESIS 
As observed by D’Arcy Wentworth in On Growth and Form in 1917,  
"An organism is so complex a thing, and growth so complex a phenomenon, that 
for growth to be so uniform and constant in all the parts as to keep the whole 
shape unchanged would indeed be an unlikely and an unusual circumstance. Rates 
vary, proportions change, and the whole configuration alters accordingly." [121] 
Although early descriptions of developmental biology focused on the variety of gross 
morphological changes that shape the embryo, modern descriptions have focused on spatial and 
temporal gene expression which patterns the embryo.  We now understand that it is a 
combination of these two ideas which lends a more precise understanding of cell and 
developmental biology where regulated gene expression influences cellular mechanics to shape 
cells, tissues, and organs.  Some examples of the molecular regulation of actomyosin dynamics 
which may influence cell behavior during development are discussed below. 
1.3.1 Actomyosin-dependent mechanisms in cell biology.  
1.3.1.1 Stress fiber formation 
Early studies described long, straight bundles of microfilaments which terminated in 
dense plaques at the base of the cell.  Because these microfilaments were thought to arise due to 
tension on the cytoplasm, they were termed stress fibers [122].  Stress fibers are bundles of actin 
filaments held together by -actinin, marked with intermittent MyosinII.  The insertion of 
MyosinII between anti-parallel actin filaments allows contractility and shortening of the bundle.  
As stated previously, RhoA seems to be a major regulator of stress fiber formation which 
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functions through Rock to activate MyosinII and mDia.  Inhibition of Rock signaling through 
overexpression of RhoE, Gem, Rad, or DN-RhoA blocks stress fiber formation [67, 68].   
The activity of both Rock and mDia is required for stress fiber formation [49].  Alone, 
Rock activation induces disorganized stress fibers in the center of the cell, whereas mDia 
overexpression forms parallel actin filaments that are loosely bundled [49].  It is the combination 
of the two which leads to the organized, contractile bundles in stress fibers.  While Rock is 
responsible for inducing MyosinII filament assembly, mDia localizes to focal adhesions where it 
is thought to nucleate actin filaments [123]. 
Stress fibers are critical for the mechanics of many cells.  As an example, endothelial 
cells of the vasculature experience continual mechanical stress from hydrostatic pressure, cyclic 
stretch, and fluid shear.  As blood flows across endothelial cells, actin stress fibers become 
enriched and aligned along the direction of flow [124].  Stress fiber formation from fluid shear 
has been connected to RhoA and Rock activation [125].  It is thought that within blood vessels, 
stress fibers help endothelial cells retain a flat and smooth luminal surface. 
1.3.1.2 Cell Migration 
As cells move, they must cycle between protrusive and contractile motions.  In a 
polarized cell, a protrusion, such as a lamellipodium, extends from the cell and attaches to the 
substrate.  Adhesion to the substrate then facilitates the contraction of the tail, allowing the cell 
to move in one direction. 
The lamellipodium is formed by Arp2/3 and branched actin networks, and as such, 
MyosinII is not required for its formation [126].  Proximal to the lamellipodium is a structure 
known as the lamellum which is composed of thick actin bundles.  Both regions undergo 
retrograde actin flow with lamellipodial actin coalescing into the bundles of the lamellum. 
 20 
Following knockdown of MyosinII or inhibition by blebbistatin, the lamellum collapses and the 
net rate of protrusion is delayed [126].  It appears that MyosinII is responsible for slowing 
retrograde actin flow in the lamellum which counters actin polymerization at the lamellipodium.  
Adhesion to the substratum balances these two opposing forces and creates traction points to 
oppose retrograde actin flow, resulting in net protrusive activity [127].  Thus, focal adhesive 
contacts create a ‘molecular clutch’ which is essential for migration.  Just as the loss of 
contractility can abolish migration, migration is also lost following excessive MyosinII activation 
[128].  There likely exists a precise amount of MyosinII activity which promotes cellular 
migration, as it has long been known that enhancing contractility also reduces migration.   
Because the molecular clutch or FA is required for some forms of migration, its 
formation is essential for function.  The lamellipodium contains nascent focal contacts to the 
substratum which begin to mature at the transition zone between the lamellipodium and the 
lamella.  MyosinII is required for the maturation of these focal adhesions [129].  There are two 
possible roles for MyosinII in FA maturation.  First, MyosinII bundles actin filaments.  As a 
consequence of actin bundling, adhesive proteins at the ends of the fibers coalesce and can form 
larger complexes [130].  Another non-exclusive possibility is that MyosinII-generated tension 
induces conformational changes in FA components, exposing additional binding sites which lead 
to maturation.  To support this hypothesis, it has been shown that when talin is mechanically 
stretched, it binds to vinculin which would serve to bind additional F-actin fibers and other FA 
proteins [131]. In this manner, the stiffness of the underlying substrate can affect the stiffness of 
the cytoskeleton. With decreased stiffness of the substrate, the clutch cannot generate sufficient 
force to remodel the actin cytoskeleton.  For example, cells grown on softer substrates contain 
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smaller, dynamic adhesions compared to cells grown on stiffer substrates which contain large, 
stable adhesions [132]. 
Within motile fibroblasts, MyosinII isoforms have different roles.  MyosinIIB localizes to 
non-dynamic actomyosin structures in the center and rear of the cell.  MyosinIIA is dynamic and 
localizes to protrusions at the cell front [133].  Additionally, MyosinIIA activity is essential for 
tail retraction.  General inhibition of MyosinII causes cells to elongate as they fail to retract the 
tail [134].  Differential localization of MyosinII isoforms establishes a front and rear to the cell 
and likely contributes to different actomyosin dynamics in these regions.  In addition, the control 
of actomyosin in migrating cells creates stable FAs and highly bundled actin.  These structures 
prevent protrusion and specify the sides of the cell [133].   
1.3.1.3 Cell adhesion 
The regulation of cell adhesion is critical in mediating the transition between 
mesenchymal and epithelial behavior.  In addition, AJs must be dynamic in order to allow cell 
rearrangement and morphogenesis in the context of a tissue while still maintaining adhesion.  
Initial E-cadherin based cell-cell contacts are dependent upon local activation of Rac which 
drives actin-based filopodial protrusions enriched with E-cadherin [135, 136].  These filopodial 
protrusions extend into neighboring cells and establish nascent cell-cell contacts which recruit -
catenin, vinculin, Mena, VASP, and formin-1 [13, 136].  Additionally, Rac can activate 
phosphatidylinositol 3-kinase leading to Cdc42 and Arp2/3 activation [136].  The combined 
effects of activating actin binding proteins at early sites of cell adhesion are thought to expand 
the area of contact between cells and extend E-cadherin interactions.   
The activities of Rac and Cdc42 can also activate Par6 and aPKC, leading to AJ 
maturation and apical-basal polarity [137].  Additionally, RhoA maintains E-cadherin based 
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cellular adhesion through control of Dia1 and Rock [138].  Actomyosin networks are critical to 
maintaining cellular adhesion as knock out of MyosinII leads to loss of E-cadherin at cell-cell 
junctions [139].  Inhibition of Rock phenocopies inhibition of MyosinII [140].  These results 
suggest that a balance of actomyosin networks and Rho family GTPases is required to promote 
and maintain adhesion.  Recent evidence has suggested a differential role for MyosinII isoforms 
in maintaining AJs.  Within MCF-7 cells the loss of MyosinIIA leads to the discontinuity of E-
cadherin within the AJC, whereas the loss of MyosinIIB depletes the apical F-actin belt.  In these 
cell lines, MyosinIIA is under the control of Rock, but MyosinIIB is regulated by Rap1 [141]. 
A mechanistic role for MyosinII in maintenance of AJs has recently been described.  AJs 
are important for maintaining the integrity of cells within a tissue, but they can also be used to 
sense and respond to mechanical cues.  Recent studies demonstrate that-catenin binds to 
vinculin in a force dependent manner.  Inhibition of MyosinII leads to the loss of vinculin at AJs, 
whereas localized MyosinII activation at AJs recruits vinculin to the areas subjected to force 
[142].  -catenin contains a region within the protein that inhibits the interaction with vinculin 
[143].  Because the actin binding region of -catenin, actin filaments, cadherin interactions, and 
MyosinII contractility are all required for -catenin and vinculin binding, a model has been 
proposed where force exerted upon AJs causes stretching of -catenin to expose the site for 
vinculin binding thereby promoting additional F-actin recruitment [143]. Such a mechanism 
ensures the localization of sufficient amounts of F-actin to maintain adhesion and balance within 
a cell population and provides insight into how cells can rapidly remodel AJs during 
development. 
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1.3.1.4 Wound closure 
The process of wound closure involves the coordination of adhesion and migration as 
cells must maintain epithelial integrity while migrating into the open space.  As thick actomyosin 
cables are present at the leading edge, it has long been hypothesized that a purse-string 
mechanism draws cells together as they migrate into the wound [144, 145].  Further analysis of 
actomyosin dynamics during wound closure of MDCK cells has revealed two roles for MyosinII.  
MyosinII is recruited to two distinct locations immediately after wounding: in a ring at the TJ 
and near lamellipodia at the base of the cell [146].  Inhibition of MyosinII blocks contraction of 
the apical ring and switches basal motility from a lamellipodia-based mechanism to a filopodia-
based mechanism [146].  Rock predominately localizes to the TJ but is the primary effector of 
MyosinII activity at both locations [146].  ZO-1 co-localizes with apical MyosinII in this system 
and has been proposed to facilitate the connection between actomyosin and TJs [146].  Once the 
apical purse string has constricted, ZO-1 localizes to the leading edge and is required for 
localization of aPKC-Par3 and PATJ, likely mediating directed cell migration through activation 
of phosphatidylinositol 3 kinase [145, 147]. 
1.3.2 Actomyosin-dependent mechanisms in development. 
Though vertebrate species show expansive diversity in adult form and function, there are striking 
gross morphological similarities between the early embryonic stages of vertebrates.  As 
infamously drawn by Ernst Haeckel in his publication Anthropogenie in 1874, the early 
developmental stages of fish, salamanders, pigs, dogs, and humans are nearly indistinguishable.   
As all vertebrates must undergo similar developmental processes such as proliferation, 
differentiation, gastulation, elongation, neural tube closure, and organogenesis, it is through 
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conserved mechanisms of cellular morphogenesis that similar structures arise.  A few roles for 
contractility during development are discussed below. 
1.3.2.1 Germline ablation of MyosinII isoforms. 
Given the significance of MyosinII in mediating cellular migration and adhesion, it is 
likely an important protein for normal development.  The in vivo implications of MyosinII 
isoforms have been addressed through germline ablation and have revealed different phenotypes 
for each isoforms.  MyosinIIA deficiency is lethal by e6.5 due to failure in cell adhesion and 
visceral endoderm formation [139].  MyosinIIB deficiency is lethal by e.14.5 due to cardiac and 
brain defects [148].  These differences suggest non-redundant functions for MyosinII isoforms, 
and in support of this notion, knock-in of MHC IIB into the MHC IIA locus in MyosinIIA 
deficient mice only rescues brain but not cardiac defects [149].  Similarly knock-in of MHC IIA 
into the MHC IIB locus in MyosinIIB deficient mice rescues cell adhesion defects but the 
embryos still die around e11.5 from angiogenesis and migration defects [150].  These results 
suggest that Myosin isoforms have overlapping but non-redundant functions.   It is hypothesized 
that actomyosin-dependent functions during development which require only the actin cross-
linking ability of MyosinII are not isoform specific, however those functions which require the 
specific kinetic properties of a particular MyosinII isoform cannot be rescued.  While many 
studies to date utilize general MyosinII inhibition in the analysis of contractility, in the future it 
will be important to consider how different isoforms impart specific functions and how they are 
differentially regulated. 
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1.3.2.2 Embryo stiffness 
During development the notochord is a well-known organizing center which produces 
morphogens to influence the differentiation of surrounding tissues.  Though disruption of the 
notochord may impart loss of developmental signaling to surrounding tissues, some evidence 
suggests that mechanical cues to surrounding tissues are lost in several model systems including 
frog [151], newt [152], and zebrafish [153].  In a process known as convergent extension which 
is dependent upon RhoA and actomyosin, cells converge upon a midline within the plane of the 
cells in order to elongate the tissue [154].  Actomyosin-induced changes in shape influence the 
elongation of the overlying neural plate.  The notochord also contains inherent tissue stiffness 
which prevents buckling during straightening of the Xenopus embryo [155].  It has also been 
demonstrated that the notochord, paraxial mesoderm, and endoderm exhibit actomyosin-
dependent differences in stiffness compared to one another [156].  It is possible then that 
differences in adhesive strength and stiffness may function in boundary formation between 
tissues and may provide mechanical support between tissues during morphogenesis, however 
such a role has yet to be examined. 
Stiffness of the underlying substrate has also been shown to be an important determinant 
of cell behavior and not just reactionary to cell signals.  When the stiffness of the substratum is 
reduced, cell spreading, stress fiber formation, and FA maturation are reduced [157].  
Mesenchymal stem cell (MSC) differentiation is dependent upon substrate stiffness.  When 
MSCs are cultured on hard substrates which mimic the physiological stiffness of bone, cells 
differentiate along an osteogenic lineage.  When MSCs are cultured upon soft substrates which 
mimic neural tissue, cells express neural markers [158].  The ability of MSCs to respond to their 
environment is dependent upon contractile actomyosin, as inhibition of MyosinII prevents 
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differentiation into all tested lineages [158].  It is likely that the ability of these cells to change 
shape underlies their ability to differentiate.  In support of this notion, RhoA activation and Rock 
activity is essential for guiding MSCs along an osteogenic lineage.  Upon ablation or inhibition 
of Rho or Rock activity, cells divert to an adipogenic lineage [159].  Rock-dependent cell shape 
changes during MSC differentiation mediate responsiveness to BMP and SMAD signaling which  
guides differentiation, however a molecular connection between the two has yet to be determined 
[160]. 
1.3.2.3 Apical constriction 
While tissue stiffness may be associated with cortical contractility of the entire cortex, 
specific localization of actomyosin can mediate more specific morphogenetic changes.  For 
example, apical constriction of the mesoderm during Drosophila gastrulation leads to 
invagination and generation of the primary germ layers.  This process is dependent upon the 
transcription factors Snail and Twist which promote activation of RHOGEF2.  RHOGEF2 then 
activates Rho and promotes the formation of apical contractile actomyosin through the 
stimulation of Rock [161, 162].  Constriction in this system is not uniform, but follows a cyclical 
pattern of brief contractility which correlates with MyosinII accumulation [163].  If such bursts 
were allowed to relax and revert to the original position, then a net change in the apical surface 
would not arise.  Thus it is hypothesized and has been observed that a ratchet-like mechanism 
exists to maintain tension between contractions.  The molecular identity of this system is 
unknown, but it also relies upon the expression of twist [163].  Pulsed apical contractility also 
plays a role in dorsal amnioserosa cells, essentially pulling the overlying epidermis towards the 
center [164]. Actomyosin also regulates apoptosis of amnioserosa cells and the leading edge 
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purse string in the epidermis.  Together with apical constriction of the amnioserosa, these 
different functions of actomyosin are required for dorsal closure [164-166]. 
Twist transcription itself is likely mediated by changes to the cytoskeleton as physical 
compression of the stomodeal cells during germband extension increases twist expression, 
inducing apical constriction of the mesoderm which will pattern the gut [167].  Experimental 
manipulation of cellular tension through uniaxial stretching of the embryo also upregulates twist 
[168].  It is intriguing that a regulator of one contraction event can be regulated by another.  
These results likely reflect the dynamic nature of contractile actomyosin networks during 
mechanotransduction, demonstrating how actomyosin networks can remodel as needed in 
response to molecular signals or force. 
1.3.2.4 Angiogenesis 
As the embryo grows in size and cell number, tissues must be properly vascularized to 
supply oxygen as needed.  The sprouting of new blood vessels from existing ones is not only 
important for development, but also for tissue engineering and vascularization of tumors.  During 
angiogenesis, cells must sprout from formerly quiescent vessels, maintaining adhesion while 
migrating towards a stimulus.  During this process, the cell at the forefront of migration is termed 
a “tip cell” while those that follow are termed “stalk cells.”  A primary activator of tip cell 
specification is VEGF, which upon binding to VEGFR2, stimulates a signal transduction cascade 
which activates Delta-like 4 (Dll4) [169].  Through lateral inhibition, Dll4 activates Notch 
signaling in neighboring cells which in turn, downregulates VEGFR2 expression, ensuring that 
only tip cells respond to VEGF [170]. 
Early studies of capillary morphogenesis identified filopodial extensions within the tip 
cells which guide migration [171].  Increasing evidence suggests that VEGF activates Rho 
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GTPases to influence cell migration within the tip cell.  Both Cdc42 and Rac1 are activated by 
VEGF which induces filopodia and lamellipodia respectively [172, 173].  VEGF also activates 
RhoA in endothelial cells.  Expression of D/N RhoA or inhibition of Rock abolishes VEGF-
induced changes in the actin cytoskeleton and prevents angiogenesis [174, 175].  Indeed, 
stimulation of individual endothelial cells with VEGF increases their contractility in a Rock-
dependent manner [176].  However conflicting reports on the role of Rock in angiogenesis exist 
such that Rock inhibition or knockdown in a retinal neovascularization model actually enhances 
angiogenesis [177].  Consistent with these results, MyosinII can be visualized at the endothelial 
cell cortex and is lost prior to sprouting activity [178].  Localized inhibition of Rock abolishes 
cortical MyosinII localization and promotes sprouting, suggesting that Rock induced contractility 
negatively regulates branching [178].  It was recently demonstrated that an ideal level of cellular 
adhesion to the substrate promotes angiogenesis; too few or too many adhesions can be 
detrimental to angiogenesis [179].  While it is difficult to compare the role of Rock in different 
endothelial cell lines and angiogenesis models, it may be that differential responses to Rock 
inhibition create differences in cellular adhesion thus altering the angiogenic response.  
Determining how angiogenic signals induce sprouting in relation to contractile actomyosin in 
vivo will be an important task in understanding developmental angiogenesis and the development 
of anti-tumor drugs.     
1.4 THE SHROOM FAMILY OF PROTEINS 
The first Shroom protein was serendipitously identified in 1992 while trying to generate a cDNA 
against the  subunit of a Na+, K+ –ATPase in Bufo marinus.  Named after the characterization 
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of its localization, Apical Protein from Xenopus leavis (APX) was identified as a protein 
essential for amiloride-sensitive sodium channel activity but was not a physical pore component 
[180].  Subsequent experiments confirmed a role for Apx in epithelial sodium channel activity 
(ENaC) [181] and suggested apical localization was due to the formation of a macromolecular 
complex containing -spectrin [182].  Additional studies found related proteins in mammals, 
named APX-like (APXL) [183], Shroom [184], and KIAA1202 [185].  Identified as distinct 
family members with conserved domains rather than as homologues to the Xenopus APX, the 
proteins were renamed in the chronological order in which they were identified: Shroom1 (Apx), 
Shroom2 (Apxl), Shroom3 (Shroom), and Shroom4 (KIAA1202) [186].   
The Shroom family of proteins is characterized by possession of several conserved 
domains: an N-terminal PDZ domain, a central Shroom Domain 1 (SD1), and a C-terminal 
Shroom Domain 2 (SD2) [187, 188].  At present, the function of the PDZ domain remains 
unclear, as it is not required for Shroom3 function nor for Shroom4 localization and only mildly 
affects Shroom2 localization [188, 189].  The SD1 lies near an actin binding region, yet while 
not all Shroom proteins contain an SD1, they all bind F-actin. [188, 190, 191].  The only domain 
common to all family members is the SD2 (Figure 5 and Table 1).  The SD2 is required for the 
formation of Shroom-dependent actomyosin networks and has recently been shown to physically 
bind to Rock 1/2 [189, 192].  Thus far, only Shroom3 and dShroom have been shown to 
physically interact with Rock, however due to the high degree of conservation amongst the SD2 
of all family members and the ability of all members to induce morphological changes, Rock 




Table 1: Overview of Shroom family of proteins 
Previous name Current name Domains Present Actin Binding? 
APX Shroom1 SD1   SD2 Y 
APXL Shroom2 PDZ   SD1   SD2 Y 
Shroom L Shroom3 PDZ   SD1   SD2 Y 
KIAA1202 Shroom4 PDZ             SD2 Y 






1.4.1 Shroom3 and implications for conserved Shroom family functions. 
The ability of Shroom family members to induce cell shape change in a variety of animal model 
systems and tissues will be described in the following sections. The first example of a 
morphogenetic role for Shroom proteins was identified for Shroom3 in which mutant mice were 
generated through a series of gene trap mutagenesis experiments in embryonic stem (ES) cells 
[184].  Shroom3 mutant embryos show open neural tubes at embryonic day (e) 9.5 and extensive 
neural tube defects by e14.5 including exencephaly (100%), facial clefting (87%), spina bifida 
(23%), and ventral closure defects which result in organ herniation (12%) [184].  Though ventral 
closure defects occur infrequently, 100% of Shroom3 mutant ventral neural tubes are malformed 
with a collapsed lumen, apparent loss of rigidity, and aberrant roof plate morphogenesis [184].   
Within murine neural epithelia and MDCK cells, Shroom3 localizes to tight junctions and 
induces apical constriction and apical-basal epithelial lengthening [187, 189, 193].  It is believed 
that Shroom3-induced morphogenesis is sufficient to induce wedge-shaped cells which promote 
neural plate bending and subsequent NT closure [187].  The necessity of Shroom3 for apical 
constriction and NT closure is consistent in other model systems as depletion of Shroom3 in 
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Xenopus and chick embryos also leads to aberrant epithelial morphology and NT closure defects 
[187, 192]. 
In addition to expression within the neural epithelium, Shroom3 is expressed within most 
developing epithelial tissues particularly the optic pit, hindgut, foregut, lungs, and somites [184].  
Shroom3 likely contributes to morphogenesis of these tissues, as Shroom3 mutant embryos also 
display defects in lens placode invagination and foregut looping, each of which are attributed to 
the loss of apical constriction and epithelial lengthening [194-196]. 
Shroom-induced epithelial lengthening is thought to occur through tubulin recruitment 
to the apical surface, orienting MTs along the apico-basal axis [194, 197].  As Shroom proteins 
and apical  tubulin have not been shown to interact and do not precisely co-localize, apical 
tubulin localization could be a secondary effect.  A direct role for Shroom3 and apical 
constriction is better understood. The ability of Shroom3 to induce apical constriction is 
dependent upon its ability to bind to actin and establish a contractile MyosinII-dependent 
network [189, 195].  Interestingly, Shroom3 is the only family member which induces apical 
constriction of MDCK cells when over expressed, yet all Shroom proteins retain the ability to do 
so when properly targeted.  When a chimeric protein is generated in which the SD2 of Shroom3 
is replaced with another family member’s SD2, apical constriction is rescued [188].  Because 
apical constriction is dependent upon the SD2 through physical recruitment of Rock and 
establishment of actomyosin networks, this suggests that all Shroom proteins have the ability to 
elicit morphogenetic changes through actomyosin recruitment.  
Why then can not all Shroom proteins elicit apical constriction in MDCK cells?  There 
are seemingly two possibilities.  First, while all Shroom proteins can bind to actin, they may do 
so in different ways.  This is best demonstrated in Rat1 fibroblasts as Shroom2, Shroom3, and 
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Shroom4 all display differential actin-based localization.  In Rat1 cells, Shroom3 can bind and 
bundle F-actin stress fibers; Shroom2 cannot bundle actin and preferentially localizes to cortical 
actin; and Shroom4 uniquely recruits actin into unknown structures which perpendicularly span 
stress fibers [188, 190].  Specifically how these proteins interact with different populations of F-
actin may influence apical constriction.  It might also be possible that Shroom proteins bind actin 
with different affinities.  Second, unique protein binding partners have been identified for several 
Shroom proteins (Figure 5) which will be elaborated upon in the following sections.  In regards 
to Shroom3, Shroom3 is the only family member to possess an EVH1 domain.  Deletion of this 
region or transfection of the Mena EVH1 domain which acts as a D/N blocks apical constriction 
[195].  Because the EVH1 domain of Shroom3 is required for apical constriction, it is likely that 
other interacting proteins, the identity of which remains to be determined, are necessary for 
morphogenesis.  Plenty of SH3s (POSH), a multi-domain scaffolding protein which assembles an 
active JNK / MAPK module also interacts with Shroom3 [198].  Such an interaction is required 
for negative regulation of axon length [199].  From these observations it is clear that differential 
actin binding and protein interactions are important for mediating apical constriction.  
Specifically how unique proteins influence localization and whether or not they influence actin 
binding remain to be determined. 
Ultimately, precise sub-cellular localization of each Shroom protein is also important for 
its function.  In support of this notion, the SD2 of any Shroom protein can be targeted to the 
apical membrane with an Endolyn tag.  Within MDCK cells, Endolyn sorts to the apical plasma 
membrane and can be over expressed without affecting morphology [200].  Apical localization 
of the SD2 with this tag induces apical constriction [189].  Without a localization signal, the SD2 
is cytoplasmic and fails to induce morphogenetic change.  As the SD2 is not required for 
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localization of Shroom proteins, Shroom proteins likely localize through unique protein 
interactions outside of the SD2.  Determining additional protein interactions which may mediate 
localization of the Shroom proteins will be useful to elucidate specific Shroom protein functions.   
While Shroom3 influences Rock localization, precisely how Rock is activated after 
recruitment remains unclear.  Overexpression of D/N RhoA has no effect on alleviating the high 
frequency of apically constricted MDCK cells after Shroom3 expression [187].  While D/N Rap1 
can abolish apical constriction, Rap1 has not been shown to regulate Rock activity [187].  Rap1 
was recently shown to mediate the connection of the actin cytoskeleton with AJs in Drosophila 
through regulation of the Afadin homologue Canoe.  Loss of either Rap1 or Canoe leads to a 
striking accumulation of actomyosin balls which have detached from AJs, preventing 
morphological change [114].  These results may explain the effect of D/N Rap1 on eliminating 
Shroom3-dependent apical constriction as the cytoskeleton may have lost association with AJs.  
Alternatively, MyosinIIB is regulated by Rap1 in MCF-7 cells [141], so it might be that 
Shroom3 functions primarily through MyosinIIB.  Because D/N RhoA fails to abolish apical 
constriction, it remains a possibility that physical interaction of Rock with Shroom proteins is 
sufficient for activation.  Interestingly, the region with which Rock binds to Shroom lies just N-
terminal to the RhoA binding site [192]. Because intermolecular inhibition of Rock is relieved by 
an interaction with RhoA, it is an appealing idea that Shroom activates Rock in a similar manner.  
There is no current evidence for post-translational modification of Shroom proteins.   
Transcriptional regulation can influence cell morphogenesis by controlling the presence 
or absence of key regulators within a cell population.  Two examples of transcriptional 
regulation have been identified for Shroom3.  First, Pax6 is a transcription factor present in the 
lens placode which is essential for shroom3 expression [195].  A direct or indirect effect for Pax6 
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remains to be determined.  Second, Pitx1 is required for shroom3 expression within the Xenopus 
gut.  The promoter of shroom3 contains several Pitx1 consensus sequences.  When this promoter 
is attached to a luciferase reporter, Pitx1 increases expression 18-fold, implicating a direct role 
for Pitx1 and shroom3 expression in the gut [194]. 
1.4.2 Shroom2 
Shroom2 was first identified by sequencing genes within a large X-chromosomal deletion 
thought to underlie Ocular albinism type 1 (OA1) [183].  OA1 is an X-linked disorder which 
causes impairment of visual acuity, involuntary eye movement, misalignment of the eye, and 
retinal hypopigmentation.  Shroom2 lies upstream of the OA1 gene, yet its role in OA1 remains 
unclear [183].   
The best support for the involvement of Shroom2 in ocular albinism comes from studies 
in Xenopus.  When expressed within naïve epithelial blastomeres, Shroom2 ectopically recruits 
pigment to the apical surface [197].  Shroom3 exhibits similar activity, yet consistent with 
previous studies in MDCK cells, Shroom3 induces apical constriction while Shroom2 does not.  
Shroom2 is expressed within the developing eye and when knocked down by morpholino, loss of 
Shroom2 leads to hypopigmentation and disruption of Retinal Pigment Epithelium (RPE) 
morphology [197].  The exact role for Shroom2 in this process is unclear, but morphological 
change brought about by Shroom2 activity may help establish apical accumulation of  tubulin 
and apical / basal oriented MTs for pigment transport [197].  A second hypopigmentation 
disorder, ocular albinism with sensorineural deafness (OASD), also maps to the same region of 
the X-chromosome as OA1 [201, 202].  Because Shroom2 is expressed within epithelial cells of 
the retina and the inner ear in mice [188, 203], Shroom2 is a likely candidate for mediating 
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proper development of such organs, disruption of which may lead to sensory diseases such as 
OA1 and OASD.  There is currently no Shroom2 mutant mouse to address such questions.  As 
Shroom2 is also expressed within the embryonic vasculature, gut, neural tube, and kidney [188] 
and a variety of adult epithelial tissues [203], additional studies are necessary to understand 
Shroom2 function in these tissues. 
MyosinVIIa is an unconventional myosin which is abundant at cell-cell junctions and 
binds to vezatin, a transmembrane protein incorporated into the cadherin-catenin complex [204].  
Mutations in MyosinVIIa lead to Usher syndrome type I, identified by congenital deafness, 
vestibular dysfunction, and progressive retinitis pigmentosa [205, 206].  Through a yeast two 
hybrid screen, Shroom2 was identified as an interacting protein, binding to MyoVIIa through a 
region N-terminal to the SD1 (a.a. 350-721) [203].  The smallest MyoVIIa construct which binds 
to Shroom2 contains the MyTh4 and FERM domain.  However, interaction with MyoVIIa does 
not likely mediate Shroom2 localization, as Shroom2 still localizes to TJs of hair cells in 
MyoVIIa defective shaker-1 mice [203, 207].  Both MyoVIIa and Shroom2 are important for 
proper melanosome biogenesis and apical localization [197, 208]. In addition, Shroom2 and 
MyoVIIa are localized to inner hair cells of the ear [209, 210].  Therefore, it will be interesting to 
examine the relationship between the two for insight into the development of certain auditory-
visual disorders. 
 Consistent with the observation that MyoVIIa is not sufficient for Shroom2 localization, 
the PDZ and Serine/Proline Rich region (SPR) (a.a. 1-513) of Shroom2 localize efficiently to TJs 
in MDCK cells [188]. In order to elucidate the molecular target of Shroom2 at the TJ, Etournay 
et al. performed a yeast two hybrid with Shroom2 PDZ/SPR bait against an inner ear cDNA 
library.  They identified and confirmed ZO-1 as an interacting partner with an interaction 
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between the SH3/GuK domains of ZO-1 and the SPR region of Shroom2 [203].     Interestingly, 
the PDZ domain of Shroom2 is not essential for the interaction with ZO-1.  However, the 
relationship between ZO-1 and Shroom2 in the context of a cell is not as straightforward.  While 
TJ formation has been shown to precede Shroom2 recruitment, Shroom2 localizes to cortical 
actin and nascent adherens junctions devoid of ZO-1 [188, 203].  More importantly, in 
fibroblasts which express E-cadherin and form junctions which contain ZO-1 but lack true TJs, 
Shroom2 fails to localize [203].  These observations suggest that either a multi-step process or 
multi-protein complex at mature TJs is responsible for Shroom2 localization.  Additionally, it 
may be that Shroom2 can interact with other ZO proteins, as murine ZO-1 and ZO-2 share 66% 
identity within the SH3/GuK region.  ZO-1 and ZO-3 share 49% identity within the same region. 
The mechanism of Shroom2 localization is confounded further because the PDZ domain, a 
common domain of scaffolding proteins and TJ-associated proteins, is not required for Shroom3 
localization and only mildly affects Shroom2 localization in vitro yet contains 64% identity 
between Shroom2 and Shroom3 [184].  As Shroom3 also localizes to TJs and shares loose 
similarity to Shroom2 within the SPR, Shroom3 may also interact with ZO-1. 
1.4.3 Shroom4 
Gross defects in morphogenesis can be severely detrimental, i.e. lethal, to an organism.  More 
subtle defects in morphogenesis may allow survival yet severely disable the organism.  As a 
consequence of subtle neural defects, mental retardation affects 1-3% of the population.  Over 
10% of these cases are due to mutations or gross chromosomal abnormalities within the X 
chromosome, termed X-Linked Mental Retardation (XLMR) [211].  A number of genes 
responsible for XLMR involve actin dynamics including several Rho effectors and actin binding 
 37 
proteins [212].  Two XLMR patients have been identified with causative X chromosome 
breakpoints within Shroom4 [185].  As Shroom4 is an actin binding protein which can induce 
MyosinII dependent changes in the cytoskeleton, it is likely that defects in neural morphogenesis 
underlie the development of XLMR in Shroom4 defective patients [190].  As Shroom4 is 
expressed within the epithelium of many adult and embryonic structures, additional studies will 
be essential to elucidating Shroom4 interactions and function [190]. 
1.4.4 Shroom1 
hShroom1 was recently identified in a yeast two hybrid screen as an interacting protein with 
melanoma cell adhesion molecule (MCAM) [213].  Within which region of Shroom1 MCAM 
interacts remains unclear.  hShroom1 contains the characteristic SD1 and SD2 of the Shroom 
family and may bind to F-actin, however the SD2 of Xenopus Shroom1 is more similar to 
hShroom2, 3, and 4, suggesting that hShroom1 is not the homologue of  Xenopus Shroom1 
[213].  hShroom1 is expressed in brain, heart, skeletal muscle, colon, small intestine, kidney, 
placenta, lung, and melanoma cells lines.  In addition, it is strongly expressed in a variety of 
tumor tissues, yet its role in such cells has yet to be determined [213]. 
1.4.5 dShroom and evolutionary implications for the Shroom family 
Based on homology to the SD2, the invertebrate Drosophila ortholog, dShroom, was identified 
[188].  While the SD2 is the only region of conservation between dShroom and vertebrate 
Shroom proteins, dShroom still retains the ability to bind to F-actin.  Two isoforms, dShroomA 
and dShroomB are detectable with dShroomA as the most abundant isoform.  dShroomA, the 
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longer isoform, localizes to AJs which are in a synonymous location as vertebrate TJs.  
dShroomB is shorter, lacks the actin binding motif, and localizes to the surface of epithelial cells.  
dShroomA and dShroomB both induce different actomyosin networks based on their 
localization.  When overexpressed in the dorsal ectoderm, dShroomA induces robust apical 
constriction from AJs while dShroomB assembles a disorganized actin network at the apical 
surface.  Consistent with vertebrate Shroom proteins, dShroom-induced actomyosin networks are 
dependent upon an interaction between the SD2 and dRok [191]. 
Despite a lack of sequence conservation in the N-terminus between dShroomA and 
vertebrate Shroom3, they share localization to a particular region which is conducive to apical 
constriction.  As dShroom does not contain a PDZ, SD1, or any other region of similarity with 
vertebrate Shroom proteins outside of the SD2, it appears selective pressure was exerted upon 
Shroom3 to maintain the appropriate localization conducive for apical constriction [191].  It is 
then quite possible that other Shroom proteins were adapted for additional Rock-dependent 
functions as more complex mechanisms evolved. 
The SD2 appeared very early in the animal lineage as a distantly related open reading 
frame is identified in the cnidarian Hydra magnipapillata and potential orthologs are found in the 
ascidian Ciona intestinalis and the echinoderm Strongylocentrotus purpuatus [188].  Unlike 
dShroom, the predicted proteins from the sea squirt and sea urchin contain a PDZ domain.  As 
yeast and Arabidopsis thaliana genomes do not contain any Shroom-like proteins, it is likely that 
Shroom is an animal specific protein; however not all animals possess shroom as the nematode 
worm Caenorhabditis elegans and the flatworm Schmidtea mediterranea contain no clear 
orthologs.  Phylogenetic analysis of SD2 sequences in vertebrates suggests that a duplication of 
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the ancestral Shroom gene gave rise to two homologues, one that became Shroom4 and one that 
duplicated again to form Shroom2 and Shroom3 [188].  
1.4.6 Summary 
The Shroom proteins are regulators of epithelial morphogenesis, best characterized by their 
ability to organize actomyosin networks.  All Shroom proteins are characterized by their ability 
to bind F-actin and by high conservation of the C-terminal SD2 which binds to Rock.  
Establishment of actomyosin networks relies upon two modules within the Shroom proteins.  
First the protein must properly localize through actin binding and interaction with additional 
proteins.  Second, from specific sub-cellular locations within the cell, Shroom recruits Rock 
through an interaction with the SD2, activating contractile actomyosin.  Due to high conservation 
within the SD2 and the ability for all Shroom proteins to bind to actin and cause apical 
constriction when properly targeted, the establishment of actomyosin networks through 
recruitment of Rock is the key mechanism of Shroom function.  Unique sequences within the N-
terminus of the Shroom proteins convey unique protein interactions and differential protein 
localization.  Thus each Shroom protein may act in similar yet unique ways.  A summary of 
known domains and protein interactions is provided in Figure 5.  While Shroom3 has been well 




 Figure 5: Shroom Family of Proteins Schematic 
An overview of known protein domains (grey boxes) and known protein interactions (underlying lines). 
1.5 DISSERTATION AIMS 
To date only Shroom3 has been well defined as a regulator of epithelial morphogenesis during 
development. While Shroom2 binds to actin and mediates apical constriction of MDCK cells 
when properly targeted, no study has yet identified a role for Shroom2 in morphogenesis.  Given 
that certain endothelial cells endogenously express Shroom2 which localizes to cortical actin, 
and cortical actomyosin networks are essential for angiogenesis, we thought endothelial 
morphogenesis provides an ideal model to address Shroom2 function.  Thus, the first aim of this 
dissertation is to elucidate and characterize the function of Shroom2 in endothelial cells. 
In Xenopus embryos, Shroom2 recruits  tubulin to establish apically oriented 
microtubules for apical/basal elongation and directed transport of cargo [197].  While this 
phenomenon has not been observed in mammalian systems, I have observed Shroom2 
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localization at the centrosome, a  tubulin rich structure important for ciliogenesis and mitotic 
spindle orientation during mitosis [214, 215].   It is currently unknown how Shroom2 plays a role 
in the regulation of the centrosome.  Thus the second aim of this dissertation is to establish 
Shroom2 as a bona fide centrosomal protein, to determine how Shroom2 localizes to the 
centrosome, and to identify its role in centrosome function. 
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2.0  SHROOM2 REGULATES CONTRACTILITY TO CONTROL ENDOTHELIAL 
MORPHOGENESIS 
The intrinsic contractile, migratory, and adhesive properties of endothelial cells are central 
determinants in the formation of vascular networks seen in vertebrate organisms. Because 
Shroom2 is expressed within the endothelium, is localized to cortical actin and cell-cell 
adhesions, and contains a conserved Rho kinase (Rock) binding domain, we hypothesized that 
Shroom2 may participate in the regulation of endothelial cell behavior during vascular 
morphogenesis. Consistent with this hypothesis, depletion of Shroom2 results in elevated 
branching and sprouting angiogenic behavior of endothelial cells. This is recapitulated in 
HUVECs and in a vasculogenesis assay where differentiated embryonic stem (ES) cells depleted 
for Shroom2 form a more highly branched endothelial network.  Further analyses indicate that 
the altered behavior observed following Shroom2 depletion is due to aberrant cell contractility, 
as evidenced by decreased stress fiber organization and collagen contraction with an increase in 
cellular migration.  Because Shroom2 directly interacts with Rock and Shroom2 knockdown 
results in the loss of Rock and activated MyosinII from sites of cell-cell adhesion, I conclude that 
Shroom2 facilitates the formation of a contractile network within endothelial cells, the loss of 
which leads to an increase in endothelial sprouting, migration, and angiogenesis. 
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2.1 INTRODUCTION 
Shroom3 has been shown to be a critical regulator of cell morphology in several cellular contexts 
and animal model systems [184, 187, 189, 192, 194, 199, 216]. Shroom3-mediated 
morphogenesis is dependent on its ability to bind both F-actin and Rock [189, 192].  It is 
predicted that actin binding targets Shroom3 to the tight junction in polarized epithelia.  
Shroom3 can then recruit Rock to the tight junction, resulting in the localized activation of 
MyosinII and subsequent apical constriction [189, 192].  In addition to the ability to regulate 
actomyosin networks, Shroom3 has been implicated in regulating the apical positioning of γ 
tubulin and subsequent microtubule organization in Xenopus epithelial cells [216].  It is unclear 
if these two activities of Shroom3 are directly related or occur independently.  In vertebrates, the 
Shroom proteins contain another family member, Shroom2, which shares several structural and 
functional characteristics with Shroom3.  Like Shroom3, Shroom2 contains an N-terminal PDZ 
of unknown function, a centrally located, conserved actin binding module centered around the 
SD1, and a C-terminally located SD2, which, in the case of Shroom3, directly binds to Rock 
[188, 192].  Unlike Shroom3, Shroom2 does not induce apical constriction in either Xenopus 
ectodermal epithelium [197] or cultured MDCK epithelial cells [192].  However, Shroom2 has 
been shown to control other aspects of morphogenesis in Xenopus embryos, such as epithelial 
thickening and pigment accumulation [193, 197].  
In mice, Shroom2 is highly expressed in various populations of polarized epithelial cells, 
including the neural epithelium, gut, eye, lung, and kidney.  Additionally, Shroom2 is highly 
expressed in the endothelium of the developing vasculature [188].  This is consistent with the 
other cell types that express Shroom2, as the endothelium itself is a polarized population of 
epithelia.  Endothelial cells exhibit the remarkable capacity to undergo dramatic changes in 
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morphology and migration in order to form the network of tubes that are seen in the embryo 
during and after vasculogenesis.  Initial formation and subsequent remodeling of the vascular 
network are dependant on both the ability of endothelial cells to sprout new branches via the 
formation of filopodia and migration to new positions in the network [217].  One of the critical 
determinants of the migratory behavior of endothelial cells is MyosinII contractility downstream 
of Rock.  It has been demonstrated that inhibition of MyosinII or Rock results in increased 
endothelial sprouting, suggesting that this pathway is a critical regulator of vascular 
architecture [177, 178, 218, 219].  In this context the function of Rock seems to negatively 
regulate membrane protrusion and cell migration at the level of cortical contractility. 
Specifically, a cortical Rock-MyosinII network inhibits the ability of cells to form membrane 
protrusions and migrate. This is supported by the observation that localized addition of 
pharmacological inhibitors of this pathway results in the rapid formation of endothelial filopodial 
outgrowth followed by cell migration [178].  
In this study I have investigated the function of Shroom2 as a potential regulator of the 
cellular and angiogenic behavior of endothelial cells.  Based on previous work, I hypothesized 
that Shroom2 might regulate these biological processes via Rock localization, impacting 
subsequent contractility.  Using siRNA and shRNA approaches in both established endothelial 
cells and in primary endothelia derived from mouse ES cells, I show that depletion of Shroom2 
results in increased angiogenesis due to decreased cellular contractility.  This decrease in 
contractility appears to result from diminished Rock and MyosinII activity at the cell cortex and 
the disorganization of the actin cytoskeleton.  These alterations in cellular architecture cause 
increases in cell protrusions and alter cellular migration.  Together, these data indicate that 
Shroom2 is a vital regulator of endothelial cell behavior during vascular morphogenesis.  
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Additionally, my findings expand the inclusion of the Shroom-Rock complex in multiple cellular 
processes and suggest that this conserved signaling complex may be utilized in a variety of 
biological events that require Rock activity. 
2.2 RESULTS 
2.2.1 Knockdown of Shroom2 increases sprouting in angiogenesis and vasculogenesis 
assays 
Previous studies from our lab have described the expression and localization of Shroom2 in the 
developing vasculature of mouse embryos and the C166 endothelial cell line [188].  Because 
C166 cells are derived from the murine yolk sac [220], I sought to confirm endogenous 
expression and localization of Shroom2 in the yolk sac in vivo.  Staining of yolk sacs of e9.5 
embryos to detect both Shroom2 and PECAM-1, an endothelial specific adhesion protein, shows 
that Shroom2 is expressed throughout the yolk sac vasculature, in both large vessels (Figure 6A) 
and the capillary plexus (Figure 6B).  In addition, the Shroom2 protein is enriched at sites of 
cell-cell adhesion, similar to what is seen in the embryo proper and in C166 cells. Based on these 
data and that from other published works [220, 221], C166 cells are a viable cell type to explore 
the function of Shroom2 in endothelial cell behavior.  Therefore, I utilized siRNA to knockdown 
the expression of Shroom2 in these cells.  C166 cells treated with a control non-targeting siRNA 
(siControl) form a confluent monolayer and exhibit Shroom2 and ZO1 distribution at cell-cell 
junctions (Figure 6C).  Cells treated with Shroom2 specific siRNA (siShroom2) also form 
confluent monolayers with no appreciable change in adherens junctions or tight junctions, but 
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Shroom2 staining is virtually eliminated from the majority of these cells (Figure 6D, Figure 7A, 
B).  Consistent with the immunostaining results, Western blotting shows that Shroom2 protein is 
reduced by approximately 70% using two different siRNAs, one targeting the 3’ UTR 
(siShroom2-7) and the other targeting the coding sequence (siShroom2-8) of the Shroom2 
mRNA (Figure 6E).  Treatment of cells with siRNA did not alter the rates of proliferation (data 
not shown) and all results have been verified using both Shroom2 siRNAs, but data are typically 
shown from experiments using siShroom2-8.  Because I obtain similar results using two different 
siRNAs that target unique regions of the Shroom2 transcript, the observed phenotypes likely 
result from specific depletion of Shroom2 protein. 
 
Figure 6: Expression and knockdown of Shroom2 in yolk sac endothelial cells. 
(A-B) Murine yolk sacs at E9.5 stained with PECAM and Shroom2 antibodies show Shroom2 localization at cellular 
junctions in both large vessels (A) and the capillary plexus (B). (C-D) C166 endothelial cells were treated with a 
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nontargeting siRNA (siControl) (C) or a Shroom2-specific siRNA (siShroom2) (D) and were stained with Shroom2 
(inset) and ZO1. (E) Shroom2 knockdown from two different siRNAs was confirmed via Western blot. α-Tubulin 
was used as a loading control.  Scale bars = 25 μm. 
 
 
Figure 7: Shroom2 knockdown does not impact cellular adhesion in a monolayer. 
(A-B) siControl (A,Ai) or siShroom2 (B,Bi) C166 cells were stained with β-catenin (A,B) and Shroom2 (Ai,Bi) 
antibodies 72 hours after transfection. There is no apparent difference in β-catenin staining. Scale bars = 25μm. 
 
One hallmark of endothelial cells is their ability to form a capillary network when 
cultured on matrigel.  Control C166 cells form a multi-cellular vascular network when grown 
under these conditions (Figure 8A).  To test the role of Shroom2 in this endothelial behavior, 
siShroom2 C166 cells were plated on matrigel and allowed to undergo angiogenesis.  Under 
these conditions, not only do siShroom2 C166 cells retain the ability to form vascular networks, 
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but they actually show elevated branching capacity (Figure 8B, C).  Shroom2 remains depleted 
throughout the matrigel angiogenesis experiments (Figure 9D-E).  When fewer numbers of C166 
cells are plated (1.2x106), short cords emerge but fail to form an interconnected network, 
whereas Shroom2 siRNA increases network formation (Figure 9A-B). 
 While treatment with both siShroom2-7 and siShroom2-8 yields a more highly branched 
network, C166 cells with the greatest degree of knockdown (siShroom2-8), show areas which 
have failed to undergo cord formation (arrow, Figure 8C).  Similar outcomes have been seen 
with a broad Rock inhibitor, Y27632, such that angiogenesis is inhibited in both C166 cells (data 
not shown) and bovine retinal endothelial cells [222].  Since Shroom2-deficient endothelial cells 
form a more branched network on matrigel, I wanted to further investigate and validate the effect 
of Shroom2 loss using an in-gel sprouting angiogenesis assay.  Control siRNA and siShroom2 
spheroids of equal cell number were embedded in collagen gels, cultured for 48 hours, and then 
analyzed for the extent of sprouting.  Consistent with the matrigel angiogenesis assay, siShroom2 
cells demonstrated significantly elevated sprouting compared to control cells (Figure 8D-F).  In 
order to verify these results in a primary cell line, I confirmed expression of hShroom2 in 
primary human umbilical vein endothelial cells (HUVEC) (Figure 8G).  After transfection with 
hShroom2 siRNA, Shroom2 protein is reduced by approximately 75% (Figure 8G).  Similar to 
C166 cells, Shroom2 knockdown in HUVECs increases branching during matrigel angiogenesis 
(Figure 8 H, I).   
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 Figure 8: Transient Shroom2 knockdown stimulates angiogenesis. 
(A-C) siControl (A), siShroom2–7 (B), or siShroom2–8 (C) –treated C166 cells were plated on matrigel to examine 
angiogenic potential. Arrow indicates an area that has failed to undergo angiogenesis. (D-F) siControl (D) and 
siShroom2 (E) C166 cells were grown as spheroids for use in a collagen sprouting angiogenesis assay. 
Quantification of collagen sprouting angiogenesis is shown in (F). The numbers of branch tips are represented as the 
mean ± SD (n = 7 spheroids). (G) Western blot of Shroom2 knockdown in HUVECs. (H-I) Matrigel angiogenesis 
assay for siControl (H) and siShroom2 (I)–treated HUVECs. Scale bars = 1 mm in A-C; 125 μm in D,E,H, and I. 
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 Figure 9: Shroom2 knockdown persists during angiogenesis assays. 
(A-B) 72 hours after siRNA transfection, 1.2x106 C166 cells were plated on a matrigel-coated coverslip in a 6 
well plate and photographed after 24 hours. Lower numbers of cells fail to form an interconnected network of 
multicellular cords, however there is still a difference in branching between control (A) and Shroom2-deficient 
cells (B). (C) 1.2x106 HUVEC cells form much smaller, single cellular, capillary networks on matrigel. (D-E) 
After 24 hours on matrigel, control (D) or siShroom2 (E) C166 cords were stained directly on coverslips with 
ZO1 (Di,Ei) and Shroom2 (Dii,Eii) antibodies. No Shroom2 is detected in siShroom2-treated cells.  Scale bars = 
1mm in A-C; 25μm in D-E. 
 
While Shroom2 knockdown in both C166 cells and HUVECs leads to an increase in 
branching, these cell types form morphologically distinct networks on matrigel.  C166 cells form 
large multicellular cords, while HUVECs form a single cellular capillary-like network (Figure 9 
A-C).  Thus, I sought to determine the effect of Shroom2 knockdown in a model more similar to 
C166 cells and the vascular network observed in the yolk sac and embryo during development.  
Because C166 cells are derived from the yolk sac where initial vasculogenesis occurs, I 
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employed a vasculogenesis assay in which ES cells can be differentiated into a multicellular 
branching endothelium [223].  It should be noted that ES cells express Shroom2 endogenously 
(Figure 10A).  In order to address the role of Shroom2 in endothelial cells derived from ES cells, 
I generated cell lines that stably express Shroom2-specific shRNAs.  Shroom2 knockdown was 
confirmed via both immunofluorescence staining (Figure 10Ai, Bi) and Western blot (Figure 
10C). Stable ES cells were then grown in suspension to form embryoid bodies, allowed to 
reattach to tissue culture dishes, and grown for 9-11 days in differentiation media.  Differentiated 
cultures were fixed and immunostained against PECAM to visualize the vasculature.  Consistent 
with the results obtained using C166 cells and HUVECs, shShroom2 ES cells generate hyper-
branched endothelial networks when compared to vector control ES cells (Fig 10D, E).  When 
observed at higher magnification, the control vasculature exhibits uniform cell borders and few 
filopodial extensions (Figure 10Di).  In stark contrast, the Shroom2 deficient vasculature exhibits 
a plethora of filopodia-like extensions (Figure 10Ei).  Shroom2 remains efficiently knocked 
down after differentiation (Figure 10F-G).  Together, these experiments suggest that within the 
endothelium, Shroom2 is involved in negatively regulating vessel branching, and that this may 
be controlled at the level of the cytoskeleton. 
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 Figure 10: Stable knockdown of Shroom2 in murine ES cells enhances vasculogenesis. 
(A–C) ES cells stably transfected with the parental vector pSuper-GFPneor (pSuper) (A) or pSuper-shShroom2 
(shShroom2) (B) were stained to detect GFP and Shroom2. Knockdown was confirmed by Western blotting (C). (D-
E) After differentiation, pSuper (D) and shShroom2 (E) cells were stained with PECAM.  Boxed regions in D and E 
are enlarged in Di and Ei. While distinct boundaries exist between control endothelial and surrounding cells (Di), 
numerous filopodia-like extensions are found throughout the Shroom2-deficient endothelium (Ei) (compare arrows). 
(F-G) After endothelial differentiation of pSuper (F) or shShroom2 (G) stable ES cells, cells were stained to detect 
PECAM (Fi,Gi) and Shroom2 (Fii,Gii).  Scale bars = 25 μm in A-B and F-G; 100 μm in D and E. 
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2.2.2 Shroom2 regulates endothelial contraction through an interaction with Rock. 
Several studies have previously shown that reduced Rock and MyosinII activity correlate with 
both increased angiogenesis and increased filopodia formation in endothelial cells [177, 178, 
219].  Along these lines, Shroom2 contains the conserved SD2 motif that has been shown to 
mediate a direct interaction between Shroom3 and Rock and between Drosophila Shroom and 
dRok to facilitate apical constriction [188, 191, 192].  Based on these observations, I 
hypothesized that the increase in sprouting observed from Shroom2 knockdown is due to loss of 
Rock-mediated contractility.  To test this hypothesis, I first verified an interaction between Rock 
and Shroom2.  In GST pull down experiments, the Shroom Binding Domain (SBD) of hRock1 
interacts with Shroom2 (Figure 11A).  This interaction does not appear to be isoform specific as 
the Shroom2 SD2 interacts with endogenous Rock1 and Rock2 (Figure 11B).  In addition, the 
Shroom2 SD2 and the hRock1 SBD domain can be co-purified when co-expressed in bacteria 
(Figure 11C). This is a specific interaction, as the actin binding domain (SD1) of Shroom2 does 
not pull-down the Rock SBD (data not shown).  In C166 cells grown on coverslips, Rock 
intermittently localizes to cell-cell junctions as indicated by co-localization with ZO1 (Figure 
12A).  Importantly, this localization appears to be dependent on Shroom2, as this population of 
Rock is lost in siShroom2 C166 cells (Figure 12B).  Knockdown of Shroom2 has no effect on 
Rock expression as indicated by Western blot (Figure 11D).  Shroom2 recruitment of Rock is 
also observed in MDCK cells engineered to express Shroom2 following withdrawal of 
doxycyclin.  In the presence of doxycycline, no Shroom2 is detected and no Rock is observed at 
tight junctions (Figure 12C).  After Shroom2 induction, both Shroom2 and Rock co-localize at 
tight junctions (Figure 12D).  These data indicate that Shroom2 can directly bind Rock in vitro 
and regulate its sub-cellular distribution in vivo. 
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 Figure 11:  Shroom2 physically interacts with Rock. 
(A) A GST-tagged mShroom2 SD2 or a GST-tagged Shroom binding domain (SBD) of hRock1 were incubated with 
total cell lysate from T23 cells engineered to express myc-Shroom2 under the tetracycline response element 
promoter (T23:TRE Apxl). Following GST pull down, the Shroom2 SD2 interacts with endogenous Rock1, and the 
Rock1 SBD interacts with full-length myc-Shroom2.  (B) The GST-tagged Shroom2 SD2 was subjected to a pull 
down assay with C166 total cell lysate. The Shroom2 SD2 interacts with endogenous Rock1 and Rock2. (C) His-
tagged mShroom2 SD2 and the untagged Shroom binding domain (SBD) of hRock1 were individually or co-
expressed in bacteria. Shroom2 SD2 was purified with Ni-NTA resin and bound proteins eluted and visualized by 
SDS-PAGE and Coomassie staining. (D) There is no change in Rock1 or Rock2 protein levels 72 hours after 
Shroom2 knockdown as indicated by Western blot. 
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 Figure 12:  Shroom2 mediates the sub-cellular localization of Rock. 
(A-B) siControl (A) or siShroom2 (B) C166 cells were stained with Rock1 (Ai and Bi) and ZO1 (Aii and Bii) 
antibodies. Arrows indicate loss of Rock localization to tight junctions after Shroom2 knockdown.  (C-D) T23 
MDCK cells with inducible myc-Shroom2 expression show no Rock1 immunostaining (Cii) at tight junctions (Ciii) 
 56 
when Shroom2 expression is inhibited (Ci). Upon expression of Shroom2 (Di), Rock1 (Dii) is localized to tight 
junctions (Diii). As Shroom2 expression was leaky, cells were also treated with Shroom2 (C) or control (D) siRNA 
for 72 hours prior to immunostaining. Scale bars = 25μm. 
 
It has been speculated that Shroom proteins can regulate cell and tissue morphology by 
controlling MyosinII activity.  Based on this notion and the above results, I hypothesized that if 
Shroom2 is involved in localizing Rock to cell-cell junctions, then it may play a role in 
establishing endothelial contractility.  To test this, I analyzed the ability of Shroom2-deficient 
cells to contract collagen gels.  Control and siShroom2 C166 cells were plated on a bed of 
collagen attached to the well and allowed to form a confluent monolayer. Following monolayer 
formation, the mechanically loaded gels were detached from the well and allowed to contract for 
6 hours.  Quantification shows that Shroom2 deficient cells are not able to contract the collagen 
gel to the same extent as control cells (Figure 13A).  Collagen gel contraction is also dependent 
upon Rock, as treatment of control cells with Rock inhibitor contracted gels to a lesser extent.  
Interestingly, Shroom2-deficient endothelial cells are more sensitive to Rock inhibition and 
contract the gel less than the inhibitor or siShroom2 alone.  This sensitivity may be due to an 
interaction between Shroom2 and Rock, which helps establish endothelial contractility.  These 
results document for the first time that Shroom proteins can indeed control the contractile 
properties of a population of polarized cells. 
Activated Rock is thought to cause MyosinII contraction by directly phosphorylating the 
Regulatory Myosin Light Chain 2 (MLC2) [70] and inhibiting the targeting subunit of myosin 
phosphatase–1 (MYPT) [71].  Rock may also influence contractility by regulating actin 
dynamics through activation of LIM kinase and subsequent cofilin phosphorylation [73].  To 
examine whether or not Shroom2 knockdown affects Rock activity, I examined the 
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phosphorylation state of several downstream Rock effectors.  Interestingly, while mono-
phosphorylated MLC2 (pMLC) is unaffected, di-phosphorylated MLC2 (ppMLC) levels are 
reduced 50% in siShroom2 C166 cells (Figure 13B). These results suggest that loss of Shroom2 
leads to a loss of Rock activity.  A similar role for Rock in the regulation of ppMLC2 but not 
pMLC2  has been observed in MDCK cells [224].  Additional Rock effectors, MYPT and FAK 
[225] show reduced phosphorylation by approximately 25% while p-cofilin levels remain 
unchanged (Figure 13B). These observations suggest that the Shroom2-Rock complex could be 
working at the level of MyosinII activity to control actin organization.  To address this issue, 
control and siShroom2 cells were stained to detect ppMLC2 at cell-cell junctions (apical) and 
stress fibers (basal) (Figure 13C-F).  In control cells ppMLC can be detected at both of these 
subcellular locations (Figure 13Ci, Ei).  In contrast, the staining in cell-cell junctions is largely 
lost and the stress fiber staining is both reduced and disorganized in the siShroom2 cells (Figure 
13Di, Fi). Based on these results, Shroom2 may control endothelial contractility via the localized 
activation of actomyosin. 
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 Figure 13: Shroom2 regulates endothelial contractility. 
(A) Contractility of siControl or siShroom2 C166 cells with or without the Rock inhibitor Y27632 was assessed 
through the ability of a monolayer to contract a collagen gel. Quantification is graphed as the percentage of area of 
the original after 6 h, represented by the mean ± SD (n = 3). (B) Phosphorylation of Rock effectors was visualized 
by Western blotting. α-Tubulin was used as a loading control. Representative blots from three independent 
experiments are shown. p-MLC2, phospho-myosin light chain 2 (Ser-19); pp-MLC2, diphospho-myosin light chain 
2 (Thr-18/Ser-19); p-MYPT, phospho-myosin phosphatase binding subunit 1 (Thr-696); pFAK, phospho-focal 
adhesion kinase (Tyr-397). (C-F) Control (C and E) and Shroom2 knockdown (D and F) C166 cells were stained for 
ppMLC (Ci-Fi) and either ZO1 (C and D) or actin (E and F). Loss of Shroom2 leads to loss of pp-MLC2 at both 
stress fibers and cell–cell junctions (compare arrowheads).   Scale bars = 25 μm. 
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Because Rock activity and MyosinII contractility have been shown to play a significant 
role in the formation and organization of actin stress fibers [226, 227], I examined stress fibers in 
siShroom2 C166 cells.  In control cells, stress fibers are typically arranged in thick bundles that 
are aligned parallel to each other within the cell and appear to be contiguous with bundles in 
adjacent cells (inset, Figure 14A); a similar organization has been observed in HUVEC 
endothelial cells [228].  This organization is lost in siShroom2 cells, as stress fibers appear 
randomly oriented (Figure 14B).  A similar change in stress fiber organization can be found in 
control C166 cells treated with a low concentration of Rock inhibitor (1 M) (Figure 14C).  
Because Rock activity is required for stress fiber formation and high concentrations of Rock 
inhibitors abolish stress fiber formation, a low concentration was selected to slightly reduce but 
not eliminate Rock activity. Consistent with the idea that Shroom2 and Rock work together to 
control cell morphology, stress fibers are greatly diminished and further disorganized in 
siShroom2 cells that are treated with 1 M Rock inhibitor (Figure 14D).  Because Shroom2 is 
not detected at focal adhesions, a major regulator of stress fibers, yet changes occur in stress 
fiber organization and pFAK levels are reduced after Shroom2 knockdown, these changes may 




 Figure 14: Shroom2 influences stress fiber organization. 
(A-D) Stress fiber organization was examined by immunostaining for actin in C166 cells treated with siControl (A), 
siShroom2 (B), siControl and Y27632 (C), and siShroom2 and Y27632 (D). Inset is a merge for apical Shroom2 





2.2.3 The loss of Shroom2 influences endothelial migration 
Rock activity can enhance or inhibit cellular migration depending on the particular cell type 
[reviewed in [229]].  In order to observe the effect of Shroom2 knockdown and concomitant loss 
of endothelial contractility on C166 migration, I subjected siShroom2 C166 cells to a scratch 
wound assay.  Loss of Shroom2 significantly increases migration of C166 cells into the wound 
relative to control cells (Figure 15A). siShroom2 cells completely closed the wounds by 24 hours 
while control wounds were about 90% closed at this time (Figure 15B).  To confirm these 
results, migration was also assessed using a Boyden chamber.  Consistent with the above wound 
closing assay, siShroom2 cells demonstrate a significant increase in migration in comparison to 
control cells (Figure 15C). I next examined the effects of Rock inhibition on C166 migration.  
Rock inhibition enhances migration in both a scratch wound (Figure 15A) and Boyden chamber 
assay (Figure 15C).  After incubation with a low concentration of Rock inhibitor, Shroom2 
deficient cells migrate more quickly than with Rock inhibition or siShroom2 alone.  The opposite 
has been observed in HUVEC cells, where Rock inhibition attenuates VEGF stimulated 
migration [174].  Similarly, Shroom2 knockdown in HUVEC cells results in significant 
reduction of migration as assayed in a Boyden chamber (Figure 15D).  
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 Figure 15:  Shroom2 knockdown affects cell migration. 
(A) siControl, siShroom2, or untreated cells with Y27632 were subjected to a scratch wound assay and were stained 
with phalloidin at 1, 12, and 24 h postscratch. (B) Quantification of a scratch wound assay from live C166 cells 
treated with siControl or siShroom2, represented by the mean percentage of wound closure ± SD (n = 5). (C) 
Migration of siControl and siShroom2 C166 cells in the presence or absence of Y27632 was assessed with a Boyden 
chamber. (D) Migration of siControl and siShroom2-treated HUVEC cells in a Boyden chamber. The number of 
migrated nuclei is represented by the mean ± SEM (n = 6) in C and D.  Scale bar = 100 μm. 
 
To better understand how Shroom2 may regulate migration, I evaluated the localization 
of Shroom2 during wounding.  Wounded monolayers of C166 cells were fixed and stained to 
detect Shroom2 and actin (Figure 16A).  Two hours after wounding, Shroom2 can be found on 
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thick F-actin cables at the leading edge.  This structure is hypothesized to resemble a purse 
string, drawing cells into the wound [146].  At this time, Rock is also found at the leading edge.  
Again, this localization is dependent upon Shroom2, as Shroom2 knockdown abolishes Rock 
localization at the leading edge (Figure 16B, C).  12 hours after wounding, Shroom2 is diffusely 
localized at the leading edge and by 24 hours is ultimately lost from the leading edge as cells 
completely detach from the monolayer.  Because these detached cells have little Shroom2 
protein, it seems logical that reduction of Shroom2 promotes migration into the wound.  
 
Figure 16: Transient knockdown of Shroom2 regulates endothelial migration. 
 (A) Untreated C166 cells were scratch wounded and stained for Shroom2 and actin at 2, 12, and 24 h post scratch. 
Asterisks indicate cells that have detached from the epithelial sheet and have lost Shroom2 expression. (B-C) 2 h 
after scratch wounding C166 cells, Rock1 localizes to the leading edge of siControl (B) but not siShroom2 (C) C166 
cells. Immunostaining for β-catenin (Bi and Ci). Scale bars =  25 μm. 
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To better understand the consequence of long-term loss of Shroom2 function in 
endothelial cells, I generated a stable C166 cell line expressing a Shroom2 specific shRNA from 
the pSuper-GFPneor vector.  Stable expression of the shRNA leads to apparent 100% knockdown 
as Shroom2 protein is undetectable via Western blot (Figure 17A).  Analysis of the effect of 
stable Shroom2 knockdown indicates a change in morphology: a loss of dense peripheral actin 
bundles observed in control cells and an increase in filopodial extensions (Figure 17C, D).  
Control cells are often found clustered and adherent to one another, while shShroom2 cells fail to 
cluster or form stable cell-cell contacts.  shShroom2 C166 cells contain fewer central focal 
adhesions (FAs) but larger peripheral FAs (Figure 17E-H).  The loss of central FAs has also been 
observed in MEFs treated with Y27632, highlighting the importance of Rock-mediated 
contractility in FA regulation [230].  As expected, expression of shShroom2 further enhances 
migration in a Boyden chamber compared to control or transient siRNA knockdown (Figure 
17B).  Because shShroom2 cells fail to adhere to one another and form a monolayer, wound 
healing was assessed by mixing vector control (pSuper) or stable shShroom2 cells (both GFP 
positive) with wildtype C166 cells.  Monolayers were then wounded and the migration of control 
or shShroom2 cells into the wound was assayed 30 minutes later.  In controls, the GFP positive 
cells are still integrated into the monolayer (arrow) and possess robust actin belts at the leading 
edge (arrowhead) (Figure 17I).  In contrast shShroom2 cells fail to adhere to the monolayer and 
after only 30 minutes, have started to migrate into the wound, past the actin belt (Figure 17J).  
Presumably due to the increase in migration and loss of cellular adhesion, these cells fail to 
undergo angiogenesis on matrigel (data not shown). Based on these results and those presented 
above, I predict that loss of signaling via the Shroom2-Rock complex reduces that degree of 
cortical actomyosin contractility, which in turn promotes the migration of the C166 cells. 
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 Figure 17: Stable expression of shShroom2 changes endothelial morphology and enhances migration. 
(A) Western blot of transient siShroom2, stable shShroom2, or stable vector control (pSuper) C166 cells for 
Shroom2. α-Tubulin was used as a loading control. (B) Quantification of Boyden chamber migration for siControl, 
siShroom2, or shShroom2 C166 cells. The number of migrated nuclei is represented by the mean ± SEM (n = 6). (C-
D) pSuper (C) or shShroom2 (D) C166 cells were allowed to spread on fibronectin-coated coverslips for 4 h and 
were immunostained for actin. Arrowheads indicate differences in cortical actin. (E–H) pSuper (E and G) or 
shShroom2 (F and H) C166 cells were immunostained for vinculin (E and F) or phospho-tyrosine (G and H) to 
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visualize focal adhesions. (I-J) pSuper (I) or shShroom2 (J) C166 cells (indicated by GFP) were mixed with parent 
C166 cells and wounded. Cells were allowed to migrate for 30 min and were then stained for GFP and actin. Arrows 
indicate stable junctions formed between pSuper and parent C166 cells. Arrowheads indicate pSuper cells that 
contribute to the actin belt or shShroom2 cells that migrate quickly into the wound past the actin belt. Scale bars = 
25 μm. 
2.3 DISCUSSION 
The actin and Rho kinase binding protein, Shroom2, is expressed within the mouse vasculature 
during development.  Here, I demonstrate a role for Shroom2 in the regulation of endothelial 
morphology, as knockdown of Shroom2 in C166 endothelial cells, HUVECs, and differentiated 
mES cells results in increased endothelial branching.  I propose the following role for Shroom2 
in the regulation of angiogenesis during embryonic development (Figure 18).  Through the actin 
binding SD1, and perhaps through the Serine/Proline rich region (SPR) responsible for 
interaction with ZO1, Shroom2 localizes to cortical actin [188, 203].  Through the SD2, 
Shroom2 recruits Rock, which is predicted to phosphorylate the MRLC and activate MyosinII, 
thereby establishing a cortical, contractile network.  As indicated by changes in stress fiber 
organization, pFAK levels, and FA architecture in Shroom2 knockdown cells, Shroom2-
dependent contractility can influence additional cellular processes including actin organization, 
cellular migration, and endothelial branching, ultimately affecting the morphology of the 
vascular network. 
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 Figure 18: Model of Shroom2 function in endothelial cells. 
Shroom2 localization to cortical actin is mediated, in part, by the actin binding domain SD1. The Shroom2 SD2 
recruits Rock to cortical actin, where it activates the myosin regulatory light chain of MyosinII, establishing cellular 
contractility. Changes in contractility are thought to influence cellular migration and branching through changes in 
actin organization, which ultimately impacts vascular morphology. 
 
It is currently unknown how the Shroom2-Rock complex might be regulated.  While 
many processes that require Rock also require the activity of Rho, previous studies suggest that 
the ability of Shroom proteins to control contraction is independent of RhoA [187, 189].  
Therefore it is possible that Shroom2 binding to Rock serves to both localize and activate the 
kinase.  It is possible that one critical step in regulation is correct sub-cellular distribution.  This 
is supported by previous observations that Shroom2, Shroom3, and Shroom4 exhibit different 
sub-cellular localization and cause different phenotypes when expressed in cells despite the fact 
that they all have the capacity to trigger MyosinII-dependent changes in cell shape [188].  While 
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actin binding is a critical aspect of the correct localization of Shroom proteins, other sequences in 
the N-terminal region, including the PDZ and SPR domains, likely contribute to their functions.  
The SPR domains of Shroom2 and Shroom3 appear to participate in direct interactions with ZO1 
and POSH, respectively, and their SH3 domains are required for these interactions [199, 203].  
Through an interaction with POSH, Shroom3 negatively regulates neurite outgrowth in a Rock-
dependent manner [199].  It is intriguing that both Shroom2 and Shroom3 can negatively 
regulate two physiologically different branching processes.  While the Shroom family of proteins 
have the capacity to alter morphology through an interaction with Rock, Shroom2 is not able to 
reproduce the apical constriction of MDCK cells caused by Shrm3 expression [188].  It is 
therefore apparent that through tissue-specific expression and unique localization mechanisms, 
the Shroom family can alter morphology in similar yet unique ways.  It has been proposed that 
the ZO1/Shroom2 interaction helps facilitate tight junction stability [203]. However, I see no 
changes in ZO1 localization following Shroom2 knockdown, and siShroom2 treated cells can 
readily form tight junctions after passage to a new plate (data not shown).  Reciprocally, ZO1 
knockdown has no effect on Shroom2 localization (Figure 19), suggesting that Shroom2 does not 
localize via ZO1 alone.  Additional experiments will be necessary to elucidate the relationship 
between ZO1, Shroom2, and the establishment of cortical contractility. 
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 Figure 19:  ZO1 knockdown does not impact Shroom2 localization. 
(A-B) siControl (A) or siTJP1 (ZO1) (B) treated C166 cells were stained with ZO1 (Ai, Bi) and Shroom2 (Aii,Bii) 
antibodies 72 hours after transfection. Following ZO1 knockdown, there is no appreciable change in Shroom2 
localization. Scale bars = 50μm. 
 
The Shroom proteins are characterized by their evolutionarily conserved Rock binding 
domain, SD2 [188, 192].  These results demonstrate an interaction between the SD2 of Shroom2 
and Rock.  I also show that Shroom2 is required for localization of Rock at endothelial tight 
junctions, and that Shroom2 deficient C166 cells are more sensitive to Rock inhibition, 
decreasing contractility and increasing migration.  These data support a role for Shroom2 in the 
localization of Rock and establishment of endothelial contractility, the loss of which results in 
increased angiogenesis.  Interestingly, near complete reduction of Shroom2 through stable 
expression of shRNA or incubation with a Rock inhibitor completely abolishes matrigel 
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angiogenesis of C166 cells (data not shown).  Because transient knockdown with Shroom2 
siRNA leads to an increase in branching, I propose that a certain level of Shroom2 / Rock-
dependent contractility threshold exists such that slight reductions in contractility increase 
branching, whereas significant reduction abolishes angiogenesis.  It is also likely that Shroom2 
mediates only a subset of Rock activity essential for angiogenesis, as Rock activation and 
localization can be regulated by other factors such as RhoA, lipids, and Dynamin I [66].  And 
while Shroom2 can interact with both Rock1 and Rock2, it remains to be determined whether or 
not the different Rock isoforms impact angiogenesis 
Conflicting reports for the role of Rock in angiogenesis have been well documented 
(reviewed in [231]).  Many of these studies utilize general Rock inhibitors which present the 
possibility of off-target effects.  Here, I suggest that Shroom2 is involved in a specific aspect of 
Rock activity during angiogenesis, specifically the cortical recruitment of Rock and activation of 
downstream MyosinII activity.  The unique ability of Shroom2 to recruit Rock to a specific sub-
cellular location, suggests that Shroom2 may provide a novel way to target specific Rock-
dependent processes while leaving others unaffected.  Several studies of the role of Rock in the 
vasculature support our findings and predictions.  Rock RNAi increases endothelial sprouting in 
both HUVEC spheroid culture and murine retinas [177].  It has also been demonstrated that local 
loss of MyosinII cortical contractility results in filopodia-like extensions in endothelial cells 
[178].  Additional studies suggest that Rock-dependent actomyosin contractility can lead to VE-
cadherin accumulation at endothelial cell-cell junctions promoting cell adhesion, inhibition of 
VEGFR2, and vessel quiescence.  Perturbation of this system through Rock inhibition or 
knockdown of VE-cadherin leads to an increase in vessel sprouting [218].   The phenotypic 
outcome of Shroom2 knockdown is reminiscent of that observed following VE-cadherin 
 71 
knockdown such that both lead to increased cord formation and decreased MLC2 
phosphorylation [218]. Interestingly, following transient knockdown of Shroom2 in C166 cells, I 
do not see changes in cell-cell adhesion, as measured by -catenin and ZO1 staining. Therefore, 
it appears that the ability of Shroom2 to control contractility and subsequent endothelial 
morphogenesis may be independent of cadherin-mediated adhesion.  However, it should also be 
noted that C166 cells are devoid of VE-cadherin (data not shown) and thus may use another 
cadherin for cell-cell interactions that does not function in an analogous manner to VE-cadherin.  
Another distinction between these experimental systems is that C166 cells do not require the 
addition of VEGF, suggesting that the relationship between VEGF, VE-cadherin, and 
morphogenesis has been uncoupled in these cells. This suggests that there may be different, 
independent pathways working to promote the formation of peripheral actomyosin networks 
which control the angiogenic behavior of endothelial cells. Alternatively, it could be that these 
two pathways may intersect at the level of the cortical actin network in adherent cells in order to 
reinforce one another and that both are required to maintain cortical contractility and restrict the 
migratory and branching potential of endothelial cells. The link between cadherin signaling and 
Shroom2 will be an interesting and valuable avenue of investigation. 
In conclusion, I show that Shroom2 is expressed in the developing vasculature and is 
required for proper angiogenesis.  Reducing Shroom2 levels with Shroom2 RNAi decreases 
endothelial contractility and leads to increased endothelial sprouting.  Because Shroom2 
physically interacts with Rock and Shroom2-deficient cells are more sensitive to Rock inhibition, 
I propose that Shroom2 and Rock interact to regulate cellular contractility which in turn controls 
cytoskeletal architecture, motility, and ultimately, endothelial angiogenesis. 
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3.0  SHROOM2 IS A CENTROSOME-ASSOCIATED PROTEIN IMPORTANT FOR 
CENTROSOME DUPLICATION 
The Shroom proteins are regulators of epithelial morphogenesis and are characterized by their 
ability to bind both F-actin and Rho-kinase (Rock), an activator of contractile, nonmuscle 
MyosinII.  In this section, I describe the characterization of a novel function for Shroom2 in the 
regulation of centrosome duplication.  The centrosome consists of two orthogonal microtubule 
structures termed centrioles which duplicate precisely once during the cell cycle.  Disruptions to 
the temporal, spatial, or numerical control of centrosome duplication can lead to extra 
centrosomes which have been linked to chromosomal instability and cancer.  Through 
immunostaining, biochemical isolation, and exogenous protein localization, I demonstrate that 
Shroom2 is a centrosome-associated protein.  Chronic depletion of Shroom2 leads to inhibited 
proliferation, increased multi-nucleation, and ectopic centrosomes.  Results from deletion and 
rescue analysis suggest that Rock activity is required for Shroom2 function at the centrosome.  






Shroom-family proteins are regulators of epithelial morphogenesis and are essential for the 
development of vertebrate tissues such as the neural tube [184, 187, 192], gut [194, 196], lens 
placode [195], and vasculature [232].  In vertebrates, the Shroom2-4 proteins have been 
characterized by two distinct activities.  First, all contain a highly conserved C-terminal SD2 that 
binds to Rock1/2 [184, 188, 192, 232] and leads to subsequent activation of Myosin II.  Second, 
these proteins directly bind F-actin.  Actin dependent localization of Shroom proteins and their 
recruitment of Rock to specific sub-cellular locales is important in the establishment of 
contractile actomyosin networks required for apical constriction and subsequent neural tube 
closure, bending of lens epithelium, looping of the gut, and branching morphogenesis of 
endothelial cells [184, 187, 189, 192, 232].   
While the ability to bind both Rock and actin is conserved amongst the Shroom proteins, 
Shroom family members may not function redundantly.  For example, only Shroom3 can elicit 
apical constriction of either MDCK cells or ectodermal cells in Xenopus embryos [188].  
However, in such a model of apical constriction, when chimeric proteins are generated in which 
the Shroom3 SD2 is replaced with a Shroom2 or Shroom4 SD2, apical constriction is rescued 
[188].  This confirms the importance of the SD2 / Rock interaction in mediating morphogenesis, 
but also suggests the importance of the N-terminus in defining localization and/or function.  
Consistent with this notion, I have recently identified the importance of Shroom2 and Rock in 
controlling endothelial cell morphology as described above.  These results suggest that in 
endothelial cells, Shroom2 is targeted to the cortical actin cytoskeleton and cell-cell junctions, 
likely through actin binding and a Serine/Proline-rich region shown to interact with ZO-1 [188, 
203].  Shroom2 then recruits Rock to these sub-cellular locales.  In these cells, transient 
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knockdown of Shroom2 leads to aberrant Rock distribution, a loss of cortical contractility, and 
increased angiogenesis [232].   
While Rock1 and Rock2 are well-defined regulators of cytoskeletal dynamics and 
architecture, they also play important roles in centrosome biology.  The centrosome consists of 
two orthogonally aligned centrioles which are surrounded by an amorphous protein matrix 
known at the pericentriolar material (PCM).  The centrosome duplicates precisely once during 
mitosis to ensure the proper assembly of a bi-polar spindle (reviewed in [233]). Initiation of 
duplication is tightly controlled to ensure proper centrosome number.  In mammalian cells, a 
procentriole forms perpendicular to the wall of each parent centriole around the G1/S transition.     
A primary regulator of centrosome duplication is Polo-like kinase 4 (Plk4).  Inhibition of Plk4 
blocks centrosome duplication, whereas overexpression induces excessive duplication, however 
the specific targets of this kinase remain unknown [234, 235].  Additional procentriole 
components have been identified which determine centriole structure such as Sas6, CPAP, and 
Cep135.  Upon initiation of duplication, SAS6 and Cep135 form a procentriolar ‘cartwheel’ 
which forms the structural basis for the nine-fold symmetry of the microtubules [236, 237].  
CPAP also localizes to the procentriole before MT assembly and is required for initial 
attachment of singlet MTs [238]. CPAP may also regulate centriole length as overexpression 
results in abnormally long centrioles [239].  By unknown mechanisms, the existence of the 
procentriole limits additional centriole duplication [240].  Disengagement of orthogonal 
centrioles during anaphase is required for initiation of duplication and relies upon the activity of 
separase, however the protein which engages orthogonal centrioles and the substrates of separase 
during disengagement are unknown [241]. 
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Deregulation of centrosome duplication can lead to excess centrosomes which perturb 
proper spindle assembly, promote chromosome segregation errors, and ultimately promote 
chromosomal instability and tumorigenesis [242, 243].    Rock2 localizes to the centrosome and 
participates in centrosome duplication such that overexpression of constitutively active Rock2 
promotes centrosome duplication and down-regulation of Rock2 inhibits duplication [244].  
While regulators of Rock2 activity at the centrosome have been identified, such as Morgana/chp-
1 and Nucleophosmin (NPM)/B23, it remains unclear how Rock2 localizes to the centrosome 
and which effectors mediate centrosome duplication [244, 245].   
Here I present evidence through immunofluorescence, biochemistry, and domain 
mapping that Shroom2 is a centrosome-associated protein.  In order to determine whether or not 
Shroom2 regulates centrosome function, I examined an endothelial cell line deficient for 
Shroom2 which was described in section 2.2.3.  With little to no Shroom2 protein, these cells 
exhibit inhibited proliferation, increased multi-nucleation, and inefficient centrosome 
duplication.  Despite the observation that centrosomes duplicate less efficiently without 
Shroom2, knockdown cells may assemble extra centrosomes through the accumulation of centrin 
aggregates.  The excess centrin and centrosome phenotypes are rescued upon reintroduction of 
RNAi-resistant Shroom2 protein and is dependent upon the SD2 and Rock.  Taken together, our 




3.2.1 Shroom2 is a centrosome associated protein. 
To confirm Shroom2 as a centrosome associated protein, I co-stained HUVECs, C166, HeLa, 
and NIH 3T3 cells to detect both Shroom2 and γ tubulin, a marker of the PCM (Figure 20).  
Results from these experiments suggest that Shroom2 is localized to the centrosome.  In all cell 
lines tested, significantly less Shroom2 protein is observed at the centrosome during Anaphase, 
yet returns by G1 phase (Figure 20).  To validate Shroom2 immunostaining at the centrosome, I 
fixed and immunostained HeLa cells with two different Shroom2 sera.  Both sera mark the 
centrosomes (Figure 21A-B).  In all cell lines tested, Shroom2 and  tubulin immunostaining do 
not precisely correlate, indicating that Shroom2 does not localize to the PCM. Therefore I 
examined Shroom2 localization in relation to centrin, a protein incorporated into the distal ends 
of centrioles [246].  Shroom2 localizes precisely between the two distal centrin puncta, 
suggesting that Shroom2 either lies at the proximal end of centrioles or is a linker between the 
two centrioles that comprise the centrosome (Figure 21C).  To further confirm that Shroom2 is a 
centrosome-associated protein, I purified centrosomes by sub-cellular fractionation of C166 cells 
and subjected the fractions to Western blot analysis.  In this assay, Shroom2 co-sediments with γ 
tubulin in the fractions that correspond to the density at which centrosomes typically sediment 
(Figure 21D).  Based on these observations, I conclude that Shroom2 is a centrosome-associated 
protein.  Within the Shroom family, localization to the centrosome is likely specific to Shroom2 
as I cannot detect either Shroom3 or Shroom4 in centrosomes (Figure 22). 
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 Figure 20: Shroom2 localizes to the centrosome in a variety of cell lines. 
(A-D) C166 (A), HeLa (B), HUVEC (C), and NIH 3T3 (D) cells were immunostained with Shroom2 and  tubulin 
antibodies and TO-PRO (blue).  In all tested cell lines, centrosomal Shroom2 is diminished in anaphase and 
telophase.  C166 cells contain a significant amount of cytoplasmic Shroom2. In A, cells were transiently transfected 
with siRNA specific for Shroom2 to eliminate the cytoplasmic population.  Scale bars = 10m. 
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 Figure 21: Shroom2 is a centrosome-associated protein. 
(A-B) Hela cells stained with two different Shroom2 sera also show localization of Shroom2 at the centrosome.  
Displayed images are representatives of G2 (A, B) and metaphase (Ai, Bi).  Cells were also stained with TO-PRO 
(blue).  All Insets are a magnification of the centrosome denoted by an asterisk.   tubulin (top), Shroom2 (bottom). 
(C) C166 cells were permeabilized, fixed, and immunostained with affinity-purified Shroom2 and centrin 
antibodies.  Regions of magnification are boxed.  (D) Centrosome isolation through sucrose density gradients 
indicates that Shroom2 is present in the centrosome fraction.   Scale bars = 10m. 
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 Figure 22:  Localization to the centrosome is Shroom2-specific. 
(A-B) Hela cells stained with Shroom3 (A) or Shroom4 (B) sera show no localization at the centrosome.  Displayed 
images are representatives of G2 (A, B) and Metaphase (Ai, Bi).  All insets are a magnification of the centrosome 












 To determine the region important for Shroom2 localization at the centrosome, I 
generated a series of hShroom2 deletion mutations and expressed these in Cos7 cells.  Beginning 
from the C-terminus, these constructs delete a series of motifs known to influence Shroom2 
localization and function.  They include the C-terminal SD2, a central, actin binding motif, a 
MyoVIIA binding region, a Serine / Proline-rich region (SPR) thought to interact with ZO-1, and 
an N-terminal PDZ domain of unknown function (Figure 23A) [188, 203].  All deletion 
constructs were tagged at the C-terminus with GFP protein.  When expressed in Cos7 cells and 
subject to Western blot, all truncated proteins exhibit the appropriate molecular mass (Figure 
23C).  In order to determine localization to the centrosome, constructs were transiently expressed 
in Cos7 cells and detected by immunofluorescence. Many deletion constructs, including 
hShroom2 full-length (FL) GFP localize to the centrosome in a manner consistent with 
endogenous protein (Figure 23B, 23D-G, Figure 24). While hShroom2 1-513 GFP localizes to 
the centrosome (Figure 23F), hShroom2 1-128, which contains only the PDZ domain, does not 
(Figure 23G).  These results suggest that amino acids 128-513, which contain the SPR, are 
important for centrosome localization of Shroom2. 
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 Figure 23: Characterization of Shroom2 localization to the centrosome. 
(A) Schematic of known Shroom2 domains (boxes) and interactions (bars). (B) Schematic of deletion constructs 
with a C-terminal, GFP fusion or N-terminal, myc fusion and indication whether they localize to the centrosome (+) 
or not (-). (C)  Western Blot (anti-GFP) of Cos7 lysate after transient transfection of the indicated constructs.  (D-G) 
Representative images of Cos7 cells transiently transfected with hShroom2 FL GFP (D), hShroom2 1-1334 GFP (E), 
hShroom2 1-513 GFP (F), and hShroom2 1-128 GFP (G).  Localization to the centrosome was visualized by 
immunostaining with GFP and  tubulin antibodies.  Insets are a magnification of the boxed region.  Merge (top),  
tubulin (middle), GFP (bottom).  Arrows indicate the centrosomes of untransfected cells with no GFP staining.  
Scale bar = 10m. 
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 Figure 24: hShroom2 GFP constructs localize to a similar location as endogenous protein. 
Cos7 cells transiently transfected with hShroom2 1-719 GFP were permeabilized, fixed, and immunostained with 
GFP and centrin antibodies.  The region of magnification is boxed. Scale bar = 10m. 
3.2.2 Shroom2 is required for centrosome function. 
To determine if Shroom2 is important for centrosome function in C166 endothelial cells, I stably 
knocked down Shroom2 with two different shRNAs (shShroom2-7, shShroom2-8) expressed 
from the pSuper vector.  As described above, little to no Shroom2 protein is detected in these 
cells via Western blot (Figure 17A).  Upon selection of stable knockdown cells, I observed 
decreased proliferation in both shShroom2 C166 cell lines compared to control (Figure 25A).  
Stable knockdown of Shroom2 also leads to a significantly higher percentage of multinucleated 
cells compared to control (Figure 25B).  Because inhibited proliferation, multi-nucleation, and 
chromosomal instability can result from defects in centrosome duplication, I examined 
centrosome number in these cells [247].  Compared to control, in which 4% of cells have ectopic 
centrosomes, 28% of shShroom2-7 and 26% of shShroom2-8 cells have three or more 
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centrosomes, as indicated by  tubulin immunostaining (Figure 25C-H).  While many shShroom2 
C166 cells lack Shroom2 staining at the centrosome and possess ectopic centrosomes (Figure 
25G), some cells with normal centrosome numbers exhibit detectable Shroom2 staining at the 
centrosome (Figure 25E, H).  In these cells, some transcripts may have escaped the RNAi 
machinery so that enough Shroom2 protein is made to function at the centrosome.  
Overexpression of Shroom2 yields no observable defects in centrosome function (data not 
shown).  These results suggest that loss of Shroom2 at the centrosome disrupts centrosome 
duplication.   
 
 
Figure 25: Shroom2 deficiency induces mitotic defects. 
(A) C166 cells were stably transfected with parental vector (pSuper) or one of two shRNAs against Shroom2 
(shShroom2-7, shShroom2-8).  shShroom2 C166 cells proliferate less than control. Average cell number is 
represented ± SD of triplicate experiments.  (B) shShroom2 C166 cells display a significant increase in multi-
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nucleation compared to control cells.  Population percentage is represented ± SD of triplicate experiments.  (C) 
shShroom2 C166 cells were stained with  tubulin antibodies to determine centrosome number.  A higher percentage 
of Shroom2 deficient cells possess ectopic centrosomes compared to control. Population percentage is represented ± 
SD of triplicate experiments.  For (A-C) at least 100 cells were counted per cell line per experiment. (D-H) Control 
(D-Eii) or shShroom2 (F-Hii) C166 cells were immunostained with Shroom2 (Eii, Gii, Hii) and  tubulin (Ei, Gi, Hi) 
antibodies and TO-PRO (blue).  A magnification of the boxed region represents ectopic (G) or normal (H) 
centrosomes.  Robust Shroom2 staining can be observed at the centrosome in control cells (D,Eii).  In shShroom2 
C166 cells, Shroom2 is absent from the centrosomes of many cells (F,Gii).  In shShroom2 cells with normal 
centrosome numbers, Shroom2 immunostaining resembles control (Eii,Hii).  Scale bars = 10m. 
 
In order to determine the nature of shShroom2-induced ectopic centrosomes, I stained 
shShroom2 C166 cells to detect centrin.  Interestingly, Shroom2 deficiency causes a striking 
accumulation of centrin aggregates in more than 80% of shShroom2 C166 cells, compared to 6% 
in control cells (Figure 26).  Ectopic centrosomes, as indicated by γ tubulin, always contain 
centrin protein, suggesting they are not PCM fragments.  However, each mature centrosome 
should contain two centrin puncta corresponding to the two centrioles.  This is not the case, as I 
frequently observe small γ tubulin puncta co-localized with large centrin aggregates (Figure 
26B).  This suggests that ectopic centrosomes may form through de novo centriole assembly.  In 
this process, centrin aggregates accumulate without a mother centriole, and over the course of the 
next cell cycle, mature into functional centrosomes [248]. The centrin aggregates in shShroom2 
C166 cells are not pre-centriole intermediates, as they contain neither SAS-6, a proximal 
centriole protein, nor acetylated tubulin (Figure 27, data not shown).   
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 Figure 26: Loss of Shroom2 leads to ectopic centrin aggregates. 
(A-B) pSuper control (A) or shShroom2 (B) C166 cells were immunostained with  tubulin (Ai, Bi) and centrin (Aii, 
Bii) antibodies and TO-PRO (blue).  Shroom2 deficient cells display ectopic centrin aggregates compared to control 
cells. (C) Quantification of centrin puncta in pSuper and shShroom2 C166 cells.  Population percentage with normal 
or abnormal centrin is represented as the mean ± SD. At least 100 cells were counted in triplicate per cell line.  Scale 
bars = 10m. 
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 Figure 27: Ectopic centrin aggregates are not pre-centrioles. 
(A-B) pSuper (A) and shShroom2 (B) C166 cells were immunostained with centrin (Ai, Bi) and SAS-6 (Aii, Bii) 
antibodies and TO-PRO (blue).  Scale bars = 10m. 
 
To determine if centrin aggregates are the result of a loss of Shroom2, I attempted to 
rescue centrin accumulation by transiently transfecting GFP control or full-length hShroom2-
GFP, which is shShroom2 resistant.  Transfected cells were grown for 48 hours, stained to detect 
centrin and hShroom2 GFP, and binned based on either normal (one or two centrin puncta) or 
abnormal (excess centrin puncta) centrin staining.  Full-length hShroom2 significantly rescues 
the excess centrin phenotype compared to control (Figure 28A, C).  This activity at the 
centrosome is specific to Shroom2 as Shroom3 fails to rescue centrin aggregates (data not 
shown). 
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3.2.3 Shroom2 activity is required for proper centrosome duplication. 
While microtubules are vital to centrosome function, cortical contractility through F-actin and 
MyosinII are also important for centrosome function [249, 250]. Because long term Shroom2 
knockdown in C166 cells leads to changes in cortical contractility and actin organization, I 
sought to rule out the influence of actin dynamics by measuring duplication directly through a 
centrosome duplication assay [232].  Such an assay is possible in cells with defective p53 
signaling where incubation with DNA synthesis inhibitors such as aphidicolin, blocks DNA 
synthesis but permits centrosome duplication [251].  C166 cells were created through expression 
of the fps/fes proto-oncogene [220] and likely are defective in p53 signaling, as centrosome 
duplication persists after exposure to aphidicolin (see below).  For this experiment, pSuper or 
shShroom2 C166 cells were exposed to aphidicolin or DMSO for 48 hours at which point 
centrosome number was determined.  The ratio of average centrosome numbers between DMSO 
and aphidicolin treated cells was used to determine the fold change in centrosome number.  In 
these experiments, control C166 cells exhibit an approximate 2-fold increase in centrosome 
number.  In contrast, cells with a Shroom2 deficiency do not duplicate centrosomes as 
efficiently, exhibiting only a 1.25 fold change in centrosome number (Figure 28D).  These 
results suggest that centrosome duplication is negatively impacted by the absence of Shroom2.  
Because the loss of Shroom2 also yields an increase in centrin accumulation, I propose that 
ectopic centrosomes arise through the formation of centrin aggregates and that Shroom2 is 
required to maintain the efficiency of centrosome duplication. 
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3.2.4 Rock is required for Shroom2 function. 
It has been well documented that Shroom family proteins bind and act via Rock through 
interaction with the C-terminal SD2 [188, 192, 232].  Because it has been shown that Rock1 and 
Rock2 are important for centrosome positioning and duplication respectively, I sought to 
determine whether Shroom2 activity is dependent upon Rock.  To investigate this possibility, 
Shroom2 deficient C166 cells were transiently transfected with expression vectors for either 
GFP, full-length GFP tagged hShroom2, or a GFP-tagged hShroom2 1-1334, which lacks the 
SD2, and assayed for centrosome number 48 hours post transfection.  Expression of GFP- 
hShroom2 restores normal centrin in approximately 50% of the cells.  In contrast, expression of 
the SD2 deletion mutant fails to rescue the excess centrin phenotype compared to GFP alone 
(Figure 28B, C).  To further show that this activity of Shroom2 is working through Rock, I 
performed this rescue experiment in the presence of the Rock inhibitor Y27632.  Y27632 
abrogates the ability of Shroom2 to rescue ectopic centrin (Figure 28C). Rock inhibition itself 
does not lead to ectopic centrin accumulation (Figure 29).  These results suggest that Rock is 
essential for Shroom2 function at the centrosome.  A Shroom2 construct with the N-terminal half 
deleted, mShroom2 880-1479, also fails to rescue the centrin phenotype (Figure 28C).  As seen 
with other Shroom proteins, the need for full-length protein suggests that proper targeting of 
Shroom2 is essential for mediating Rock activity [187, 189].  
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 Figure 28: Ectopic centrin can be rescued by exogenous Shroom2. 
(A-C) shShroom2 C166 cells were transiently transfected with GFP, hShroom2 FL GFP, hShroom2 1-1334 GFP, 
hShroom2 FL GFP with 10 M Y27632, or myc-mShroom2 880-1479 and immunstained to detect centrin. (A-B) 
Representative images of hShroom2 FL GFP (A) and hShroom2 1-1334 GFP (B).  Inset is centrin. (C) Population 
percentage of cells with normal centrin puncta is represented ± SD of triplicate experiments.  (D) pSuper and 
shShroom2 cells were subjected to a centrosome duplication assay.  The ratio of the change in average centrosome 
number is indicated ± SD of three experiments.  For (C,D) at least 100 cells were counted per cell line per 
experiment.  Scale bars = 10m. 
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 Figure 29: Rock inhibition does not lead to ectopic centrin aggregates. 
(A-B) C166 cells were treated with DMSO (A) or 10M Y27632 (B) for 48 hours and immunostained to detect 
centrin and  tubulin.  Scale bars = 10m. 
 
The presence of supernumerary centrosomes is a common trait of many human tumors 
[252].  In addition, centrosome amplification promotes tumorigenesis in Drosophila, implicating 
conservation of centrosome-mediated carcinogenesis [253].  While it had been believed that 
extra centrosomes may promote tumorigenesis through formation of multi-polar spindles and 
aneupoloidy, it has recently been shown that mechanisms exist to cluster multiple centrosomes 
into two poles [254, 255].  As a result, multipolar spindles occur infrequently, and even then, 
such progeny mitotically arrest or apoptose [243].  It is more likely that extra centrosomes form 
multipolar spindle intermediates prior to anaphase where merotelic kinetochore attachments 
cause lagging chromosomes, segregation errors, and chromosomal instability [243].  Ectopic 
centrosomes in shShroom2 C166 cells still cluster during anaphase, however chromosomal 
bridges caused by lagging chromosomes are frequently observed (Figure 30).  In addition to 
spindle formation and tumorigenesis, the centrosome plays a critical role in the formation of 
cilia.  During interphase, many mammalian cells extend a primary cilia which is nucleated by a 
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centrosome termed the basal body.  Shroom2 localizes to the basal body in retinal pigmented 
epithelial (RPE) cells (Figure 31).  As C166 cells do not form cilia in culture, a role for Shroom2 
in ciliogenesis has yet to be investigated. 
 
 
Figure 30: Shroom2 deficient cells contain lagging chromosomes. 
(A-B) Asynchronous pSuper (A) or shShroom2 (B) C166 cells were fixed and immunostained for  tubulin and  
tubulin and TO-PRO (blue).  Stages of mitosis are indicated.  Arrowhead indicates clustering of ectopic 
centrosomes.  Arrow indicates lagging chromosomes.  Scale bars = 10m.  
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 Figure 31:  Shroom2 localizes to the basal body of cilia. 
RPE1-hTert cells were grown to confluency, fixed, and immunostained with Shroom2 and acetylated tubulin 
antibodies and TO-PRO (blue).  Scale bar = 10m. 
3.3 DISCUSSION 
From these results, I provide the first evidence for Shroom2 as a centrosome-associated protein.  
Localization to the centrosome was first observed in C166 endothelial cells after transient 
transfection with siRNA against Shroom2 [232]. This was the first study to employ knockdown 
of Shroom2 in order to elucidate function in cell culture, and because cytoplasmic Shroom2 
protein can obscure visualization of the centrosome, centrosomal localization may have passed 
unnoticed in other studies.  Nonetheless, it is intriguing that centrosomal Shroom2 protein 
remains at the centrosome after transient knockdown.  This suggests that centrosomal Shroom2 
is either highly resistant to degradation or localizes with high affinity or by post translational 
modification, such that any protein still expressed after RNAi preferentially localizes to the 
centrosome.  Results from several different experiments, including immunohistochemistry, 
biochemistry, and localization of exogenous protein, indicate that Shroom2 is a bona fide 
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centrosome protein.  Although the centrosome localization domain of Shroom2 lies within amino 
acids 128-513, further experimentation is required to identify the resident protein(s) that recruits 
Shroom2 to the centrosome. 
While this is the first study to implicate Shroom2 in centrosome function, a connection 
between Shroom2 and  tubulin has been established in Xenopus.  In these studies, expression of 
Shroom2 in blastomeres leads to apical recruitment of  tubulin which is proposed to be essential 
for epithelial lengthening and pigment accumulation in Retinal Pigmented Epithalial (RPE) cells 
[193, 197].  Shroom3 functions similarly in this system, yet the mechanism of  tubulin 
recruitment by Shroom proteins remains to be determined [216].  With regards to mammals, the 
only relationship reported between Shroom2 and  tubulin comes from these experiments which 
demonstrates that centrosomal localization is specific to Shroom2 and not Shroom3 or Shroom4. 
Stable, long term knockdown of Shroom2 in C166 cells leads to decreased proliferation, 
increased multi-nucleation, excess centrin aggregates, and ectopic centrosomes.  However when 
subjected to a centrosome duplication assay, shShroom2 C166 cells duplicate centrosomes less 
efficiently than control.  Because of these observations, it is likely that extra centrosomes derive 
from centrin aggregates in a process known as de novo centrosome assembly, whereby 
centrosomes are assembled in the absence of a centriole template. Under normal conditions, the 
mother centriole serves as a base for the formation of the daughter centriole.  Mechanisms exist 
to ensure the proper spatial, temporal, and numerical duplication of centrioles (reviewed in 
[256]) as well as to inhibit de novo assembly [257].  In mammalian cell lines, as displayed in 
CHO and HeLa cells, de novo centriole assembly can occur in the absence of a centrosome [248, 
258].  After centrosome ablation in HeLa cells, centrin aggregates converge upon each other and 
mature into a  tubulin-containing centrosome over the course of the next cell cycle [248].  While 
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Shroom2-deficient cells still retain centrosomes, they display a striking accumulation of centrin 
aggregates.  These observations suggest that knockdown of Shroom2 has uncoupled the 
mechanisms which regulate centrosome number or the de novo pathway.  The precise nature of 
excess centrin accumulation and the mechanistic connection between Shroom2 and centrosome 
regulatory mechanisms remains to be determined. 
Possible insight for Shroom2 function at the centrosome comes from previous studies of 
Rock2.  Rock2 is a known centrosome-associated protein which specifically localizes between 
centrioles.  Rock2 is important for centrosome function, as knock down inhibits centrosome 
duplication [244].  Another centrosome protein NPM/B23 is a positive regulator of Rock2 
activity.  Upon phosphorylation of NPM/B23 on Thr199 by CyclinE/cdk2, NPM/B23 acquires 
high binding affinity for Rock2, increasing its kinase activity 5-10 fold [244].  This process is 
opposed by Morgana/chp-1 which blocks the interaction between NPM/B23 and Rock2, 
inhibiting centrosome duplication [245].  The small GTPases RhoA and RhoC have also been 
shown to be important for Rock activity at the centrosome [259]. Though these proteins 
influence Rock2 activity at the centrosome, they are not sufficient for Rock2 localization.  It has 
been proposed that an unknown interaction with the coiled-coil region of Rock2 is essential for 
its localization to the centrosome [244].  Interestingly, Shroom2 binds to Rock2 within the 
coiled-coil region [191, 192, 232].  Because the ability to rescue ectopic centrin accumulation 
relies upon an interaction between Shroom2 and Rock2, Shroom2 is an excellent candidate as the 
mediator of Rock2 localization at the centrosome (Figure 32).  Due to the subcellular localization 
of Shroom2 during mitosis, it remains a possibility that Shroom2 and Rock mediate linkage of 
centrioles with subsequent regulation of Rock activity initiating centrosome duplication.  
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Additional studies will be necessary to characterize such an interaction and to identify kinase 
targets at the centrosome.   
 
 
Figure 32: Model of Shroom2 function at the centrosome. 
(A) Shroom2 localizes to centrosomes through amino acids 128-513 and likely recruits Rock to the centrosome 
through its SD2. Once CyclinE/cdk2 phosphorylates Thr199 on NPM/B23, NPM acquires high binding affinity for 
Rock2 and increases Rock2 kinase activity 5-10 fold.  (B) The localization of Shroom2, Rock, and NPM/B23 are all 
essential for efficient centrosome duplication though their effectors remain unknown. 
 
 In conclusion,  I have demonstrated that Shroom2 is a centrosome-associated protein.  
Long term loss of Shroom2 leads to centrosomal defects such as delayed centrosome duplication, 
excess centrin accumulation, hindered proliferation, and lagging chromosomes.  Because 
Shroom2 interacts with Rock2 and this interaction is necessary to rescue ectopic centrin 
aggregates, I propose that recruitment of Rock2 to the centrosome is mediated by Shroom2 and 
is essential for efficient centrosome duplication.  Because centrosome defects promote genetic 
instability and are a feature of many cancer cells, it will be interesting to investigate a role for 
Shroom2 in tumorigenesis in future studies. 
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4.0  CONCLUSIONS AND FUTURE HYPOTHESES 
4.1 SHROOM2 MEDIATES THE SUB-CELLULAR LOCALIZATION OF ROCK 
Chapter 2.0 describes the characterization of Shroom2 in endothelial cells.  Because the Shroom-
family proteins are capable of inducing MyosinII-dependent actomyosin networks, I 
hypothesized that Shroom2 was important for mediating contractility in endothelial cells.  
Following Shroom2 knockdown, endothelial sprouting was enhanced, suggesting that Shroom2 
negatively regulates angiogenesis.  As Shroom2 deficient cells cannot constrict a gel as 
sufficiently as control, Shroom2 likely mediates angiogenesis through the control of contractility.  
These results suggest that Shroom proteins may influence the contractility of an entire tissue.  
During the course of this work, it was shown that Shroom3 physically interacts with Rock 
through the SD2 [192].  Because all Shroom family members share high similarity within the 
SD2 [188], I tested whether or not Shroom2 also interacts with Rock.  I was able to demonstrate 
a physical association between Shroom2 and Rock and also demonstrate Shroom2-dependent 
sub-cellular localization of Rock at the cell cortex, supporting a role for Shroom2 in establishing 
cortical contractility.  These findings are significant, because Rock has historically been thought 
of as a cytoplasmic kinase with little to no specific localization patterns in vivo [229].  My results 
demonstrate that Shroom2 is responsible for the localization of Rock to the cortex, and this 
precise localization is necessary for Rock activity. 
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How then does Shroom2 mediate Rock activity through sub-cellular localization?  There 
are several possibilities.  First, Shroom2-dependent localization of Rock may simply place Rock 
in close proximity to activation signals.  While RhoA is a key activator of Rock, previous studies 
suggest that the ability of Shroom proteins to control contraction is independent of RhoA [187, 
189].  As lipids have also been shown to activate Rock [260], it could be that localization to the 
cortex is sufficient to allow lipid-activation of Rock.  As a second possibility, the physical 
interaction between Shroom2 and Rock may be sufficient to induce activation.  The Shroom 
binding domain within Rock is located in close proximity to the Rho binding domain.  Because 
the relief of intramolecular inhibition activates Rock activity, the simple binding of Shroom2 and 
Rock may relieve intramolecular inhibition of Rock, leading to its activation.  And last, Shroom2 
may simply be a scaffolding protein which recruits all of the necessary components to establish 
actomyosin networks.  Shroom2 binds to actin and Rock, so additional, unidentified interactions 
with Rock activating proteins could exist.  One might speculate that the PDZ domain is 
important for function however it is not required for Shroom3-induced apical constriction and 
only mildly affects Shroom2 localization.  The highest region of identity between Shroom2 and 
Shroom3 lies within the PDZ domain, so its function remains an intriguing question. 
 Regardless of how Rock is activated, there are likely additional mechanisms which 
mediate the interaction between Rock and Shroom2.  For example, Shroom2 and Rock do not 
always co-localize (compare Figure 4C with Figure 10A).  Post-translational modifications such 
as phosphorylation of Shroom2 may mediate an interaction with Rock.  Another level of 
regulation could be through additional protein interactions like Gem/Rad which are hypothesized 
to block protein interactions with Rock [67]. 
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Shroom3 interacts with Rock to induce apical constriction in MDCK cells [192].  Placed 
within this same system, Shroom2 does not elicit apical constriction [188].  Because Shroom2 
can mediate the activity of MyosinII through Rock localization, it is likely that Shroom2 and 
Shroom3 enable different contractile events.  Shroom3 may promote dynamic, rapid contraction, 
and Shroom2 may promote stable, cell tension.  It will be interesting to examine the effects of 
Shroom2 expression in MDCK cells by measuring changes in cell rigidity through techniques 
such as traction force microscopy or atomic force microscopy.  Although Shroom2 shows no 
Rock isoform specificity, we have yet to examine MyosinII isoforms.  Based on the kinetic 
studies of MyosinIIB which implicate it in the maintenance of stable, tension generating fibers, it 
might be that Shroom2 promotes only MyosinIIB activity.  As Shroom2 and Shroom3 are co-
expressed and co-localize to the TJ of many epithelial tissues [188, 189, 192], it will be 
interesting to examine the relationship between the two.  A combinatorial approach to studying 
multiple Shroom proteins in morphology has yet to be addressed.   
An additional question concerning not only the Shroom proteins but the cell biology field 
as a whole is how actin binding proteins target specific populations of F-actin.  Shroom2 and 
Shroom3 both contain the SD1 and can bind to actin, however they do so differently.  Shroom3 
can bundle actin, while Shroom2 cannot.  In Rat1 fibroblasts, the SD1 of Shroom2 localizes to 
the cortex, while the SD1 of Shroom3 localizes to and bundles basal stress fibers.  Outside of the 
SD1 and SD2, unique protein interactions have been identified for Shroom3 and Shroom2, so it 
is also likely that different protein interactions influence differential localization.  Examination 
of the crystal structure of the different SD1 regions will provide valuable insight into the 
differential localization of Shroom proteins and hence the differential localization of Rock. 
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4.2 IMPLICATIONS FOR ANGIOGENESIS 
Shroom2 influences endothelial morphology through the regulation of cortical contractility.  The 
loss of Shroom2 abolishes cortical Rock localization and leads to changes in the actin 
cytoskeleton such as decreased stress fibers and increased filopodial extensions.  Because 
contractility influences adhesion and migration, Shroom2 deficiency alters the angiogenic 
potential of these cells.   
It is interesting that transient knockdown of Shroom2 exhibits different effects than stable 
knockdown in C166 cells.  With normal levels of Shroom2 and high levels of contractility, 
endothelial cells exhibit moderate angiogenic potential.  Following transient knockdown of 
Shroom2, contractility is reduced but not abolished, and these cells show the highest ability to 
undergo sprouting angiogenesis.  Finally, after near depletion of Shroom2, cortical contractility 
is largely ablated and cells can no longer undergo angiogenesis.  These results support the notion 
that an ideal level of contractility is essential to cell behavior, particularly angiogenesis, and by 
tipping the balance in one direction or the other, we can alter the outcome.  These results are 
supported by a recent study which shows endothelial cell adhesion is regulated by varying 
adhesive ligand density as an independent variable in synthetic hydrogels [179].  In this model, 
too much or too little adhesion is detrimental to angiogenesis.  As the loss of Shroom2 also leads 
to changes in stress fiber and FA organization, it is likely that contractility influences 
angiogenesis through changes in cell adhesion. 
Shroom2 knockdown may also influence the stability of adherens junctions.  While 
transient Shroom2 knockdown did not affect -catenin localization, the impact on cadherins 
remains unknown.  As I could not detect PECAM or VE-cadherin in C166 cells, it will be 
necessary to examine a more “endothelial-like” cell line which expresses these endothelial-
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specific adhesion proteins.  Based on the failure of shShroom2 C166 cells to form stable 
adherens junctions, it is likely that Shroom2 influences endothelial adhesion through the control 
of Rock activity and cortical contractility. 
Although Shroom2 interacts with Rock1 and Rock2, it is unknown if Shroom2 utilizes 
both isoforms to mediate endothelial morphogenesis.  As discussed in section 1.1.4.1, Rock may 
function redundantly in vivo, however in fibroblasts, knockdown of Rock1 and Rock2 have 
different effects.  Loss of Rock1 impedes stress fiber and FA organization, while loss of Rock2 
enhances the actin cytoskeleton.  A role for Rock isoforms in angiogenesis has not been 
addressed.  In the future, obtaining Rock2 antibodies for immunostaining and utilizing isoform 
specific siRNAs will address any differential roles for Rock1 and Rock2 during angiogenesis. 
Abnormal regulation of Rock signaling is associated with various cardiovascular diseases 
such as hypertension, coronary and cerebral vasospasm, restenosis, atherosclerosis, stroke, and 
heart failure, and thus Rock inhibitors are currently under development for clinical use [261].  In 
addition, solid tumors stimulate angiogenesis in order to supply cells with nutrients from the 
body, so developing the means to inhibit angiogenesis could effectively reduce tumor size.  In 
terms of cardiovascular disease, many drugs currently in development, such as Fasudil, are 
general Rock inhibitors.  Due to the plethora of roles for Rock in cell biology such as 
contraction, actin organization, adhesion, motility, and proliferation, general Rock inhibition 
may lead to many detrimental secondary effects.  More specific inhibitors have been developed, 
such as SLx2119, a Rock2 inhibitor, yet this only prevents promiscuity of interactions with other 
kinases and could still block all Rock2-dependent functions.  Here, I report a mechanism in 
which Shroom2 mediates only a subset of Rock activity.  These results create the possibility that 
by blocking the interaction between Shroom2 and Rock, we may effectively inhibit only one 
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facet of Rock activity in the cell, thus developing a means to specifically inhibit in vivo 
angiogenesis. 
An important question remains: what role does Shroom2 play during the formation of a 
three dimensional vascular network. No matter the assay, angiogenesis and vasculogenesis 
assays rely upon cellular adhesion, migration, and sprouting to influence the resulting network.  
Based on evidence that Shroom2 mediates Rock activity to influence these three traits in two 
dimensions, it is likely that during early stages of cord-formation, decreased adhesion and 
enhanced migration and sprouting increases branching of the vascular network.  The primary 
benefit of in vitro angiogenesis experiments lies with ease of use.  In vitro models allow for 
relatively easy manipulation of cells or growth factors to visualize the impact on angiogenesis, 
however they restrict analysis to a preslected pool of cells which do not interact in a 
heterogenous cell population [262].  Ultimately the effects of Shroom2 on angiogenesis must be 
carried out in vivo to confirm the findings described above.  The chick chorioallentoic membrane 
assay provies an in vivo tool in which endothelial cells can still be targeted for siRNA.  But 
ultimately, conditional knockout of Shroom2 in endothelial cells during development will allow 
the best physiological evaluation of the role of Shroom2 in angiogenesis.  Based on the 
experiments described above, a likely role exists for Shroom2 / Rock in the promotion of stable 
endothelial vessels.  Upon reduction of Shroom2 or Rock activity, cellular adhesion structures 
may break down, promoting endothelial migration and subsequent sprouting angiogenesis. 
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4.3 SHROOM2 AND THE CENTROSOME 
Chapter 3.0 describes the characterization of Shroom2 and the centrosome.  I have employed 
several techniques to confirm that Shroom2 is a centrosome-associated protein.  First, 
centrosome localization of Shroom2 is observed in multiple cells lines with two different 
Shroom2 sera.  Second, biochemical purification of the centrosome through sucrose gradient 
centrifugation leads to the co-fractionation of Shroom2 and the centrosome.  And finally, 
exogenous Shroom2 protein localizes to the centrosome in a manner consistent with endogenous 
protein.  These results confirm the novel localization of Shroom2 at the centrosome.  This is a 
unique observation as this is the first example of localization of Shroom2 which is not associated 
with F-actin.  While we cannot exclude the possibility that actin may be present at the 
centrosome in very small amounts, there is no significant evidence demonstrating centrosomal 
actin, and treatment of cells with the actin depolymerizing drug Cytochalasin D does not affect 
Shroom2 localization at the centrosome (data not shown).  Additionally, the region of Shroom2 
responsible for centrosome localization lies outside of the actin binding domain within a.a. 128-
513 which corresponds to the SPR.  To identify protein interactions responsible for Shroom2 
localization to the centrosome, it will be necessary to perform pull-down experiments using 
hShroom2 128-513 GFP with isolated centrosomes followed by mass spectrometry. 
I first observed centrosomal localization of Shroom2 following transient knockdown in 
C166 cells.  The observation that a population of Shroom2 protein persists at the centrosome 
after transient knockdown suggests one of two things.  First, the turnover of Shroom2 protein at 
the centrosome may be slow, thus localization persists throughout the time course of the 
knockdown experiment.  Second, Shroom2 may localize with high affinity such that any protein 
which escapes the RNAi machinery preferentially localizes to the centrosome.  Stable 
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knockdown of Shroom2 leads to a depletion of Shroom2 at the centrosome in some cells, but 
residual protein in other cells still results in Shroom2 localization to the centrosome.  This 
observation supports the hypothesis that Shroom2 has a high affinity for the centrosome.  This 
could be tested in the future through fluorescence recovery after photobleaching (FRAP). 
Long term knockdown of Shroom2 leads to centrosome defects.  Shroom2-deficient cells 
cannot duplicate centrosomes as efficiently as control.  Interestingly, a similar role for Rock2 has 
been proposed as knockdown or inhibition of Rock during centrosome duplication assays also 
hinders centrosome duplication [244].  As the ability of Shroom2 to rescue centrosome defects 
relies upon the presence of the SD2 and hence an interaction with Rock, Shroom2 likely 
mediates localization of Rock at the centrosome.  Additional experiments such as examining the 
localization of Rock at the centrosome before and after Shroom2 knockdown will be useful to 
determine the relationship between Shroom2 and Rock at the centrosome.  In addition, we can 
test if the Shroom binding domain of Rock localizes to the centrosome in a Shroom2-dependent 
manner.  Ideally, it may act as a dominant-negative, and recapitulate the Shroom2 knockdown 
phenotype.  The effectors of Rock which mediate centrosome duplication are unknown. 
While I have shown that the loss of Shroom2 directly impacts centrosome duplication 
through aphidicolin treatment, the possibility remains that shShroom2-induced changes in 
cellular architecture still affect centrosome duplication.  To exclude this possibility it will be 
necessary to show that other cellular processes or organelles such as the Golgi and nucleus are 
unaffected in the shShroom2 C166 cell line.  Alternatively, targeting Shroom2 activity to the 
apical surface with an endolyn tag would address the need for cortical contractility in centrosome 
duplication. Additionally, the development of a functional dominant-negative protein which 
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blocks localization or activity of Shroom2 at the centrosome will address any secondary defects 
brought about by long-term Shroom2 knockdown. 
In addition to defects in centrosome duplication, stable Shroom2 knockdown leads to the 
accumulation of ectopic centrin aggregates.  The nature of these aggregates is unknown, and they 
do not appear to be pre-centriole intermediates.  Centrin aggregates have also been observed in 
HeLa cells in which the centrosome has been ablated.   Over time, the centrin aggregates mature 
into a functional centrosome in a process known as the de novo centrosome assembly pathway, 
the molecular regulation of which is currently unknown [248].  To determine whether or not 
centrin aggregates following Shroom2 knockdown participate in a similar mechanism, it will be 
necessary to visualize centrin and  tubulin through live cell imaging. 
Knockout mice are great models to understand gene functions in vivo.  Unfortunately, no 
shroom2 mutant mice are available.  During the course of this work, I attempted to make 
transgenic mice through the injection of pSuper shShroom2 ES cells into blastocysts.  While I 
did recover chimeric animals, the contribution from shShroom2 cells was low, and I never 
obtained mutant embryos in subsequent crosses.  Given the role of Shroom2 in centrosome 
duplication, it is highly likely that loss of Shroom2 is deleterious to cell division and 
development.  In moving forward with the generation of shroom2 mutant mice, these results 




In summary, Shroom2 is an actin and Rock binding protein which mediates the sub-cellular 
localization of Rock to establish specific actomyosin networks that generate cellular contractility.  
Through this mechanism, Shroom2 is able to mediate a subset of Rock activities which are 
important for endothelial morphology during angiogeneiss and centrosome duplication.  As 
many other epithelial tissues express Shroom2, it will be interesting to identify additional roles 
for Shroom2 and Rock during development. 
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5.0  MATERIALS AND METHODS 
5.1 CELL CULTURE AND TRANSIENT TRANSFECTIONS 
Most cell lines were maintained at 37°C and 5% CO2 in DMEM supplemented with 10% fetal 
bovine serum, pen/strep, and L-glutamine.  Pooled HUVECs were purchased from ATCC and 
cultured in Vascular Cell Basal media (ATCC) supplemented with Endothelial Cell Growth Kit 
(ATCC).  Depending on the timing of the experiment or transfection efficiency, cells were 
transfected in suspension or while adherent with Lipofectamine 2000 (Invitrogen) according to 
manufacturer’s instructions.  Inducible Shroom2-expressing cells were made by transfecting T23 
MDCK cells with pTRE2-hygro containing a full length Shroom2 cDNA.  Cells were selected in 
EMEM/10% FBS containing 200g/mL hygromycin and 40ng/mL doxycyclin for 10 days (d).  
Individual clones were isolated, expanded, and tested by Western blotting for inducible 
expression of Shroom2 protein. 
5.2 IMMUNOHCYTOCHEMISTRY 
Cells were grown on fibronectin-coated coverslips, fixed in 4% paraformaldehyde for 20 min, 
and permeabilized with 0.2% Triton-X for 5 min or fixed in -20° MeOH for 5 min.  Fixed cells 
were then blocked with 4% Normal Goat Serum for 20 min.  Primary and secondary antibodies 
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were applied for 1 hour (h) each with three subsequent washes in PBT for 5 min each.  For 
localization mapping experiments, cells were permeabilized prior to MeOH fixation with 0.1% 
Triton-X for 20 sec followed by two rinses with PBS. Polyclonal antibodies for Shroom2, 
Shroom3, and Shroom4 were previously generated in the lab [188-190].  Additional antibodies 
were purchased: PECAM, E-cadherin (BD Biosciences), ZO1, SAS6 – clone H300 (Santa Cruz 
Biotechnology), α Tubulin,  tubulin, acetylated tubulin (Sigma-Aldrich), monoclonal  tubulin 
(Abcam), Rock1, pMLC2 – Ser19, ppMLC2 – Thr18/Ser19, p-cofilin, and pFAK-Tyr397 (Cell 
Signaling), Rock2 (Bethyl Labs), p-MYPT, centrin - clone 20H5 (Millipore), mono- and 
polyclonal GFP, TO-PRO3, goat anti-mouse, goat anti-rat, or goat anti-rabbit secondary 
antibodies conjugated to Alexa-488 or Alexa-568 (Invitrogen). 
5.3 WESTERN BLOTTING 
In most cases, cells were lysed in radio immunoprecipitation assay (RIPA) buffer supplemented 
with protease inhibitor (Sigma), separated on 10% polyacrylamide gels, transferred to 
nitrocellulose, blocked in TBST + 4% milk, and subjected to immunoblotting with HRP 
secondary antibodies.  SuperSignal West Pico Chemiluminescent Substrate was used to detect 
HRP (Thermo-Fisher Scientific).  For Western blots of phospho-proteins, cells were directly 
lysed and resuspended in sample buffer (62.5mM Tris-HCL pH 6.8, 2% SDS, 10% Glycerol, 
50mM DTT). 
 108 
5.4 RNA INTERFERENCE 
ON-TARGETplus siRNAs were ordered from Dharmacon and were tested for knockdown 
efficiency by immunofluorescence analysis and Western blotting. The following two siRNA 
duplexes were most efficient: mShroom2-7 sense sequence: AGUCAAGAUUGGCGAGA.  
mShroom2-8 sense sequence: GGAUAAUGUUGAACCCAAA.  The ON-TARGETplus 
SMARTpool for hShroom2 was used in HUVEC cells. ON-TARGETplus non-targeting siRNA 
#1 was used as a control.  C166 cells were transfected in suspension with 100nM siRNA using 
Lipofectamine2000.  Adherent HUVEC cells were transfected with 100nM siRNA using 
Dharmafect #1 (Dharmacon).  Cells were allowed to grow for 48-72 h before use. 
5.5 STABLE TRANSFECTION OF C166 CELLS 
shRNA oligos corresponding to mShroom2-7 and mShroom2-8 siRNAs (Oligoengine) were 
cloned into the pSuper-gfpneor vector (Oligoengine).  Uncut vector and both shShroom2 
constructs were individually transfected into C166 cells and after 24 h, stably incorporated cells 
were selected for G418 resistance.  Drug-resistant cells were pooled and tested via 
immunofluorescence and Western blot for GFP and Shroom2 expression.  Cell proliferation was 
measured by plating cells at the same density on day 0 and then performing hemocytometer cell 
counts every 24 h.   
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5.6 MATRIGEL ANGIOGENESIS ASSAY 
A thin layer of Matrigel (BD BioSciences) was spread onto 6-well plates and allowed to harden.  
2x106 C166 cells or 5x105 HUVECs were placed in each well with complete media.  For C166 
cells, multi-cellular chords form after 24 h and after ~5 d resolve into a thinner network with no 
change in the branching architecture [232].  Cells were photographed on an Olympus MVX10. 
5.7 SPROUTING ANGIOGENESIS ASSAY 
48 h after transfection with siRNA, spheroids of C166 cells were formed by re-suspending 400 
cells/ well in Methocel media (20% Methocel, 80% culture media) in a non-tissue culture treated 
96-well plate  which was placed at 37° overnight.  Spheroids were harvested and re-suspended in 
DMEM with 20% FBS and 30ng/mL rmVEGF (R&D Systems).  250µl of spheroids were mixed 
with 250µl of collagen (Upstate), neutralized with NaOH, and plated in a 24-well plate.  
Collagen gels were given 30 min to polymerize at 37° and were then overlaid with media and 
300ng/mL rmVEGF.  Sprouts were photographed after 48 h. 
5.8 VASCULOGENESIS ASSAY 
pSuper, shShroom2-7, or shShroom2-8 was linearized and electroporated into mouse ES cells 
(cell line AK7 – gift from Philippe Soriano).  ES cells were cultured in DMEM with L-
glutamine, Pen/Strep, 20% ES certified FBS (Thermo Scientific Hyclone), 0.1mM NEAA (Life 
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Technologies), and 0.1mM BME were grown on a layer of SNL fibroblasts (gift from Philippe 
Soriano) which had been mitotically inactivated with Mitomycin C (Sigma).  SNLs were grown 
on gelatin-coated tissue culture plates. After 24 h, positive transformants were selected in 
300ug/mL G418 for 9-11 d, changing media every day.  GFP positive colonies were selected for 
expansion and were verified for Shroom2 knockdown via immunostaining and Western blot.  
Differentiation of ES cells into endothelial vessels was performed as described by Kappas and 
Bautch (2007) [223]. Briefly, older, more flattened ES colonies were chosen for differentiation.  
ES colonies were detached with Dispase and cultured on bacteriological Petri dishes for 3 d.  
Resultant embryoid bodies were allowed to reattach on fibronectin-coated coverslips in 
differentiation media: DMEM, 20% ES certified FBS, pen/strep, L-Glutamine, 300ug/mL G418, 
and 75µm Monothioglycerol.  After 8-10 d, endothelial vessels were examined by 
immunostaining with a PECAM antibody. 
5.9 COLLAGEN GEL CONTRACTION 
1mg/mL collagen gels were prepared by diluting collagen with media, neutralizing with NaOH, 
and plating 500µL / well in a 24-well plate. C166 cells were used 48 h after siRNA transfection.  
2.5x105 cells / well in 500 µL media were placed in each well.  After 24 h, the collagen gel was 
detached with a yellow tip pipette and photographed after 6 h. 
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5.10 IN VITRO BINDING 
mShroom2 cDNA corresponding to amino acids (aa) 1286-1479 (SD2) was cloned into the 
pET151 vector which contains a His tag.  hRock1 cDNA corresponding to aa 681-942 (SBD) 
was cloned into the pRSF vector.  Both vectors were transformed into BL21 cells.  Expression 
was induced with 0.5mM IPTG for 1 h before lysing via sonication.  His-tagged SD2 was bound 
onto Ni-NTA resin, eluted with sample buffer, separated on a polyacrylamide gel, and coomassie 
stained. 
5.11 GST PULL DOWN 
mShroom2 cDNA corresponding to aa 1068-1480 was cloned into pGEX-2T and hRock1 cDNA 
corresponding to aa 593-1062 were cloned into pGEX-3X and transformed individually into 
RIPL cells.  After IPTG induction and lysing, GST-mShroom2-SD2, GST-hRock1-SBD, and 
GST alone were bound to glutathione Sepharose beads (GE Healthcare) and then incubated with 
cell lysate at 4°C for 2 h. C166 or T23:TRE Apxl (Shroom2) cells were lysed via sonication in 
NETN buffer (20mM Tris pH8.0, 100mM NaCl, 1mM EDTA, 0.5% NP-40, 1:100 protease and 
phostphatase inhibitor cocktails(Sigma)).  After incubation, glutathione Sepharose was washed 4 
times in NETN buffer, resuspended in SDS sample buffer, and analyzed via Western blot. 
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5.12 SCRATCH WOUND ASSAY 
6x105 C166 cells were transfected in suspension and plated on fibronectin-coated coverslips in a 
six-well plate.  After 72 h, cells were scratched with a yellow tip pipette to generate consistently 
sized wounds.  Representative wounds were fixed in PFA and stained with phalloidin.  To 
quantify migration, live cells at the same wound site were photographed at 1, 12, and 24 h 
postscratch and quantified by measuring the remaining wound length.  
5.13 BOYDEN CHAMBER ASSAY 
At 72 h after transfection with siRNA, 1x105 C166 cells or 7.5x104 HUVECs were plated in the 
upper chamber of a fibronectin-coated, 8.0µm polycarbonate, 24-well transwell insert (Costar, 
Corning).  Cells were allowed to migrate for 4 h.  The top chamber was scraped with a Q-Tip, 
and the bottom cells were fixed in PFA, stained with phalloidin and TO-PRO, and photographed.  
Nuclei were counted from three random fields of view of two independent experiments. 
5.14 GENERATION OF SHROOM2 GFP CONSTRUCTS 
For rescue and localization mapping experiments, I obtained hShroom2 cDNA (Image ID: 
9021734) from ATCC and through restriction digest and PCR amplification, cloned various 
fragments into pAcGFP1-Hyg-N1 (Clontech). 
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5.15 CENTROSOME ISOLATION 
Isolation of centrosomes was based on protocols developed by Moudjou and Bornes [263] and 
described by Hsu and White [264].  5x150mm confluent plates with exponentially growing cells 
were incubated with 1μg/mL cytochalasin D and 2μg/mL nocodazole in culture media for 1 h at 
37°C.  Plates were washed once with PBS, 0.1% PBS with 8% sucrose, and 8% sucrose in H2O.  
The remaining steps were carried out at 4° C.  2mL of lysis buffer (1mM Hepes pH7.2, 0.5% 
NP-40, 0.5mM MgCl2, 0.1%BME, 1:100 Protease inhibitor, 1:100 Phosphatase inhibitor cocktail 
1) was added to each plate and placed on a shaker for 10 min.  Cells were scraped and collected 
into a 15mL tube and centrifuged at 2,500g for 10 min to remove chromatin aggregates.  The 
supernatant was filtered through a 50μm nylon mesh into a glass tube and was adjusted to 10mM 
Hepes.  DNaseI (Roche, San Francisco, CA) was added to 2 units/mL and incubated for 30 min.  
The lysate was underlaid with 1mL 60% sucrose and centrifuged at 10,000g for 30 min.  2mL 
was removed from the bottom and this crude centrosome fraction was further concentrated on a 
sucrose gradient consisting of 500μL 70% sucruse, 300μL 50% sucrose, and 300μL 40% sucrose 
in 3.5mL thickwall polycarbonate tubes (Beckman, Palo Alto, CA).  The discontinuous sucrose 
gradient was centrifuged in a Beckman Ultrafuge L8-70M with a SW55TI rotor at 120,000g for 
1.5hr.  Fractions were collected from the top; 1mL for fraction 1, 0.5mL for fraction 2, and 
0.2mL for the remaining fractions.  30μL from each fraction was denatured in SDS sample buffer 
and subjected to Western blotting. 
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5.16 CENTROSOME DUPLICATION ASSAY 
Cells were plated on fibronectin-coated coverslips and allowed to spread overnight.  The 
following day, either DMSO or 2g/mL aphidicolin (Sigma-Aldrich) was added per well for 48 
h.  Cells were then fixed and immunostained for  tubulin and centrin in order to count the 
centrosome number of at least 100 cells.  The experiment was performed in triplicate, 
centrosome numbers were averaged, and a ratio between DMSO and aphidicolin-treated cells 
determined fold change in centrosome number. 
5.17 SCANNING ELECTRON MICROSCOPY 
Embryos or tissues were fixed in 2.5% Gluteraldehyde in PBT overnight and were washed three 
times for 10 min in 0.1M cocadylate.  Tissues were post-fixed for 2.5 hr in 1% osmium tetroxide 
in 0.1M cocadylate and subsequently washed 4 times for 10 min in 0.1M cocadylate.  Tissues 
were then dehydrated in 25%, 50%, 75%, and 100% EtOH for 30 min each and incubated with 
25%, 50%, 75%, and 100% HMDS in EtOH also for 30 min each.  Tissues remained in 
hexamethyldisilazane (HMDS) overnight.  Tissues were air-dried, sputter coated, and observed 
using a Jeol JSM6390LV SEM. 
5.18 STATISTICS 
All measures of significance were determined by one-tailed, unpaired t test. 
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